Original Article
Effect of Treatment of Gestational Diabetes Mellitus on Pregnancy Outcomes
N Engl J Med 2005; 352:2477-2486June 16, 2005
- Abstract
Background
We conducted a randomized clinical trial to determine whether treatment of women with gestational diabetes mellitus reduced the risk of perinatal complications.
Methods
We randomly assigned women between 24 and 34 weeks' gestation who had gestational diabetes to receive dietary advice, blood glucose monitoring, and insulin therapy as needed (the intervention group) or routine care. Primary outcomes included serious perinatal complications (defined as death, shoulder dystocia, bone fracture, and nerve palsy), admission to the neonatal nursery, jaundice requiring phototherapy, induction of labor, cesarean birth, and maternal anxiety, depression, and health status.
Results
The rate of serious perinatal complications was significantly lower among the infants of the 490 women in the intervention group than among the infants of the 510 women in the routine-care group (1 percent vs. 4 percent; relative risk adjusted for maternal age, race or ethnic group, and parity, 0.33; 95 percent confidence interval, 0.14 to 0.75; P=0.01). However, more infants of women in the intervention group were admitted to the neonatal nursery (71 percent vs. 61 percent; adjusted relative risk, 1.13; 95 percent confidence interval, 1.03 to 1.23; P=0.01). Women in the intervention group had a higher rate of induction of labor than the women in the routine-care group (39 percent vs. 29 percent; adjusted relative risk, 1.36; 95 percent confidence interval, 1.15 to 1.62; P<0.001), although the rates of cesarean delivery were similar (31 percent and 32 percent, respectively; adjusted relative risk, 0.97; 95 percent confidence interval, 0.81 to 1.16; P=0.73). At three months post partum, data on the women's mood and quality of life, available for 573 women, revealed lower rates of depression and higher scores, consistent with improved health status, in the intervention group.
Conclusions
Treatment of gestational diabetes reduces serious perinatal morbidity and may also improve the woman's health-related quality of life.
Media in This Article
Figure 1
Enrollment and Outcomes.Table 1
Baseline Characteristics of the Women.Article Activity
- Article
Gestational diabetes mellitus occurs in 2 to 9 percent of all pregnancies1,2 and is associated with substantial rates of maternal and perinatal complications. The risk of perinatal mortality is not increased,3 but the risk of macrosomia is. Other perinatal risks include shoulder dystocia, birth injuries such as bone fractures and nerve palsies, and hypoglycemia. Long-term adverse health outcomes reported among infants born to mothers with gestational diabetes include sustained impairment of glucose tolerance,4 subsequent obesity5 (although not when adjusted for size6), and impaired intellectual achievement.7 For women, gestational diabetes is a strong risk factor for diabetes.8
Although the risks associated with gestational diabetes are well recognized, it remains uncertain whether screening and treatment to reduce maternal glucose levels reduce these risks. Given this uncertainty, professional groups disagree on whether to recommend routine screening, selective screening based on risk factors for gestational diabetes, or no screening; some recommend screening,1,2,9,10 whereas others do not.11-14 There have been repeated calls for well-designed, randomized trials to determine the efficacy of screening, diagnosis, and management of gestational diabetes.1,3,15-18 We designed the Australian Carbohydrate Intolerance Study in Pregnant Women (ACHOIS) trial to assess whether the treatment of gestational diabetes would reduce perinatal complications and to assess the effects of treatment on maternal outcome, mood, and quality of life.
Methods
Design and Study Population
Eligible women had a singleton or twin pregnancy between 16 and 30 weeks' gestation, attended antenatal clinics at the collaborating hospitals, had one or more risk factors for gestational diabetes on selective screening or a positive 50-g oral glucose-challenge test (glucose level one hour after glucose challenge at least 7.8 mmol per liter [140 mg per deciliter]), and had a 75-g oral glucose-tolerance test at 24 to 34 weeks' gestation in which the venous plasma glucose level was less than 7.8 mmol per liter after an overnight fast and was 7.8 to 11.0 mmol per liter (198 mg per deciliter) at two hours.19 When the study was initiated, women meeting these criteria were classified as having glucose intolerance of pregnancy, on the basis of the World Health Organization (WHO) definition: a glycemic response to a standard oral glucose-tolerance test that was intermediate between the normal and diabetic response, with an onset or recognition of the condition during the present pregnancy.19 From 1998 onward, the WHO classified any glucose levels above normal as indicative of gestational diabetes.20 Women with more severe glucose impairment were not eligible for this trial.
Women were advised to follow a normal diet 48 hours before the oral glucose-tolerance test and to fast for 8 hours the night before the test. Blood samples were obtained after the overnight fast and one and two hours after the receipt of the 75-g oral glucose load. Women with previously treated gestational diabetes or active chronic systemic disease (except essential hypertension) were excluded.
The protocol was approved by the ethics committee at each of the 18 collaborating centers (14 in Australia and 4 in the United Kingdom). All women provided written informed consent. None of the funding bodies were involved in the trial design or conduct; collection, analysis, or interpretation of the data; or preparation, review, or approval of the manuscript.
Women were provided with written information about the study, and this information was reviewed with them orally before their oral glucose-tolerance test. They were informed that they would be eligible for randomization only if their results were in the range specified above. If they were assigned to the intervention group, they received a slip indicating a diagnosis of glucose intolerance of pregnancy and the plan for intervention, whereas if they were assigned to routine care, they received a slip indicating that they did not have gestational diabetes. This approach was continued throughout the trial, because there remained uncertainty as to the level of glucose impairment associated with adverse perinatal outcomes21; there was wide variation in the glucose levels used to define the need for treatment22; some committees,1,20 but not others,9 made changes in the nomenclature; and there was still no clear evidence of the benefits and harms of treatment.17,18 After consent had been obtained, a proportion of the women (not fewer than one in five) who had normal oral glucose-tolerance test results were assigned to the routine-care group to help maintain blinding. Women whose glucose levels exceeded cutoff values for eligibility were informed that they had gestational diabetes.
Interventions
Stratification was according to center and singleton or twin gestation. Randomization was performed centrally with the use of numbers generated by computer with variable block sizes of 6, 8, and 10. The full numerical results of the oral glucose-tolerance test were not released to the women or their providers until after birth, before discharge from the hospital.
Women who were randomly assigned to the intervention group received ongoing care by the attending obstetrical team with a physician's support. Interventions included individualized dietary advice from a qualified dietitian, which took into consideration a woman's prepregnancy weight, activity level, dietary intake, and weight gain; instructions on how to self-monitor glucose levels, which the woman was then asked to do four times daily until the levels had been in the recommended range for 2 weeks (fasting glucose levels of at least 3.5 mmol per liter [63 mg per deciliter] and no more than 5.5 mmol per liter [99 mg per deciliter], preprandial levels of no more than 5.5 mmol per liter, and levels two hours postprandially that were no more than 7.0 mmol per liter [126 mg per deciliter]), followed by daily monitoring at rotating times during the day; and insulin therapy, with the dose adjusted on the basis of glucose levels, if there were two capillary-blood glucose results during the 2-week period in which the fasting level was at least 5.5 mmol per liter or the postprandial level was at least 7.0 mmol per liter at 35 weeks' gestation or less, if the postprandial level was at least 8.0 mmol per liter (144 mg per deciliter) at more than 35 weeks' gestation, or if one capillary-blood glucose result during the 2-week period was at least 9.0 mmol per liter (162 mg per deciliter).
The care of the women in the intervention group replicated clinical care in which universal screening and treatment for gestational diabetes are available. Women in the routine-care group and their caregivers were unaware of the diagnosis of glucose intolerance of pregnancy. At the discretion of the attending clinician, if indications arose that were suggestive of diabetes, further assessment for gestational diabetes was permitted, with treatment as considered appropriate. The care of the women in the routine-care group replicated clinical care in which screening for gestational diabetes is not available. The care women and infants received was otherwise according to standard practice at each center. A research assistant extracted data on treatment from the medical records of the woman and her infant to the time of hospital discharge as well as on antenatal, birth, or postnatal complications.
Outcome Variables
Primary outcomes among the infants were a composite measure of serious perinatal complications (defined as one or more of the following: death, shoulder dystocia, bone fracture, and nerve palsy), admission to the neonatal nursery, and jaundice requiring phototherapy. The presence and severity of shoulder dystocia were assessed by means of a standardized checklist completed by the caregiver present at the birth.
Primary clinical outcomes among the women were the need for induction of labor and cesarean section. Maternal health status was assessed by means of the Medical Outcomes Study 36-Item Short-Form General Health Survey (SF-36), which assesses eight aspects of health status: general and mental health, physical and social functioning, physical and emotional role, pain, and vitality; scores on each scale can range from 0 (worst) to 100 (best).23 Maternal psychological outcomes included measures of anxiety, depression, and health-related quality of life. Anxiety was assessed with the use of the short form of the Spielberger State–Trait Anxiety Inventory,24 a self-rating scale consisting of 6 items (scores below 15 are considered normal). The presence of depression was reflected by a score of more than 12 on the Edinburgh Postnatal Depression Scale.25 Questionnaires were mailed six weeks after study entry and at three months post partum to 916 women (92 percent of the total) recruited to the study after funding for this assessment became available.
Secondary outcomes among the infants included components of the composite primary outcome, gestational age at birth, birth weight, and other measures of health. Secondary outcomes among the women included the number of prenatal visits to a health professional, the mode of birth, weight gain during pregnancy, the number of antenatal admissions, and the presence or absence of pregnancy-induced hypertension (defined as a blood pressure of at least 140/90 mm Hg on two occasions four or more hours apart) and other complications.
Statistical Analysis
Statistical analyses were based on the intention to treat and used SAS software, version 8.2 (SAS Institute). Analyses were adjusted for maternal age, race or ethnic group, and parity. Binary outcomes are presented as relative risks, with 95 percent confidence intervals; the number needed to treat to benefit (i.e., the number of patients who would need to be treated for a benefit in one patient) and the number needed to treat to harm (i.e., the number of patients who would need to be treated for harm to occur in one patient), with their 95 percent confidence intervals,26 are presented for primary clinical outcomes. Relative risks were calculated with the use of log binomial regression. Continuous variables were analyzed by means of analysis of variance if they were normally distributed and by means of nonparametric tests if their distribution was not normal. The health state utility was calculated from the SF-36 according to the method of Brazier et al.27 With no evidence of increased variance owing to the small number of twins in the study, no adjustment was made for clustering of babies with the same mothers. A P value of 0.05 was considered to indicate statistical significance; all P values were two-sided. A step-down Sidak adjustment was made for analyses involving multiple primary clinical end points.28
We estimated that we would need to enroll 1000 women for the study to have a statistical power of 80 percent (two-sided alpha value of 0.05) to detect a reduction in the risk of a serious perinatal outcome from 5.2 percent to 2.0 percent, using outcomes reported for all South Australian births29 and data from Women's and Children's Hospital in Adelaide. Data were reviewed once in January 1999 by our independent data-monitoring committee, whose members were unaware of the treatment assignments, after the enrollment of 460 women. The study protocol included a prespecified stopping rule for a difference in a major end point of at least 3 SD between the groups.
Results
Of the 1000 women enrolled in the study, 490 were assigned to the intervention group and 510 to the routine-care group (Figure 1Figure 1
Enrollment and Outcomes.). Recruitment started in September 1993 and stopped in June 2003, after 1000 women had been enrolled. Clinical outcomes were obtained up to the time of hospital discharge for all women and their 1030 infants.On the whole, the two groups were similar at entry. As compared with the women in the routine-care group, women in the intervention group were older and were less likely to be white or primiparous (Table 1Table 1
Baseline Characteristics of the Women.). Ninety-three percent of the women had been found to be at risk for gestational diabetes on the basis of the oral glucose-challenge test, and the remainder on the basis of risk factors.Primary Outcomes
The rate of serious perinatal outcomes among the infants (defined by one or more of the following: death, shoulder dystocia, bone fracture, and nerve palsy) was significantly lower in the intervention group than the routine-care group (1 percent vs. 4 percent; P=0.01, adjusted for maternal age, race or ethnic group, and parity (Table 2Table 2
Primary Clinical Outcomes among the Infants and Their Mothers.). Thus, the number needed to treat to prevent a serious outcome in an infant was 34 (95 percent confidence interval, 20 to 103). A higher percentage of infants born to women in the intervention group than of infants born to women in the routine-care group were admitted to the neonatal nursery (71 percent vs. 61 percent, adjusted P=0.01). The length of stay in the neonatal nursery among the infants who were admitted did not differ significantly between groups (median of 1 day for both groups; interquartile range, 1 to 2 days in the intervention group and 1 to 3 days in the routine-care group; adjusted P=0.81). There was no significant difference in the percentage of infants who had jaundice requiring phototherapy in the two groups (adjusted P=0.72) (Table 2).The induction of labor was significantly more common in the intervention group than in the routine-care group (39 percent vs. 29 percent; adjusted P<0.001) (Table 2). The rates of cesarean delivery were similar in the two groups (adjusted P=0.73) (Table 2), as were the reasons for cesarean delivery.
Step-down Sidak adjustments were made to correct for the analyses of multiple primary clinical end points (Table 2). The results remained consistent across these analyses, with the intervention group having a reduced risk of serious perinatal outcomes (corrected P=0.04) and an increased likelihood of admission to the neonatal nursery for the infant (corrected P=0.04) and use of induction of labor for the mother (corrected P=0.003).
Maternal health status was measured in 682 women (68 percent) who completed the questionnaires six weeks after enrollment and 573 women (57 percent) who completed them three months post partum. Women who completed assessments were slightly older than, but otherwise similar to, women who did not.
All measures on the SF-3623 showed trends in favor of the intervention group, although not all were significant (Table 3Table 3
Quality of Life during Pregnancy and Three Months after Giving Birth.). At three months post partum, fewer women in the intervention group than in the routine-care group had a score on the Edinburgh Postnatal Depression Scale25 suggestive of depression (23 vs. 50 [8 percent vs. 17 percent]). The level of anxiety was similar in the two groups (Table 3).Secondary Outcomes
No perinatal deaths occurred among the infants of mothers in the intervention group, but there were five perinatal deaths (three stillbirths and two neonatal deaths) among infants born to women in the routine-care group (Figure 1 and Table 2). Two stillbirths were unexplained intrauterine deaths at term of appropriately grown infants, and the other, at 35 weeks' gestation, was associated with preeclampsia and intrauterine growth restriction. One infant had a lethal congenital anomaly, and one infant died after an asphyxial condition during labor without antepartum hemorrhage.
There was no significant difference in the rates of shoulder dystocia between the intervention and routine-care groups (1 percent and 3 percent, respectively) (Table 2). No infant in the intervention group had a bone fracture or nerve palsy, whereas in the routine-care group, one infant had both a fractured humerus that was not related to a difficult birth and a radial-nerve palsy, one infant had Erb's palsy related to shoulder dystocia, and one infant had Erb's palsy alone (Table 2).
Infants born to women in the intervention group had significantly lower mean birth weights than infants born to women in the routine-care group (P<0.001) (Table 4Table 4
Secondary Outcomes among the Infants.), and they were also born at an earlier gestational age, in keeping with the higher incidence of induction of labor in their mothers (Table 5Table 5
Secondary Clinical Outcomes among the Women.). Significantly fewer infants in the intervention group were large for gestational age at birth, and significantly fewer had macrosomia (defined by a birth weight of 4 kg or greater) (Table 4). There was no significant difference between groups in the proportion of infants who were small for gestational age.Women in the intervention group had fewer antenatal clinic visits after enrollment than did women in the routine-care group, but they had more visits to the physician and were significantly more likely to see a dietitian and a diabetes educator (Table 5). One hundred women in the intervention group (20 percent) received insulin therapy, as compared with 17 in the routine-care group (3 percent). Weight gain from the booking appointment to the last antenatal visit was less in the intervention group than in the routine-care group (Table 5). The rates of antenatal hospital admissions were similar in the two groups. Fewer women in the intervention group than in the routine-care group received a diagnosis of preeclampsia during the antenatal period (Table 5).
Discussion
In this randomized clinical trial, treatment of women with gestational diabetes — including dietary advice, blood glucose monitoring, and insulin therapy — reduced the rate of serious perinatal outcomes (defined as death, shoulder dystocia, bone fracture, and nerve palsy) from 4 percent to 1 percent. These benefits were associated with an increased use of induction of labor for the mother and an increased rate of admission to the neonatal nursery for the infant, both of which may be related to the knowledge of the diagnosis by the attending physician. The earlier gestational age at birth as a consequence of the induction of labor may have contributed to the reduction in serious perinatal outcomes. Others have reported an increased rate of cesarean delivery associated with the diagnosis and treatment of gestational diabetes.12 In our study, the rate of cesarean delivery was similar in the two groups.
We chose primary clinical outcomes to assess the effects of treatment for gestational diabetes on both the mothers and the infants. Differences between groups remained significant after adjustment for known confounders (maternal age, race or ethnic group, and parity) and for analyses involving multiple primary end points.
Infants born to mothers receiving intensive therapy had lower birth weights than those born to women receiving routine care, an observation that may be explained at least in part by the earlier gestational age at birth in this group, related to the increased use of induction of labor. Infants in this group were no more likely to be small for gestational age, but they were significantly less likely to be large for gestational age and to have macrosomia. Infants who are large for gestational age are prone to impaired glucose tolerance or diabetes in later life, and girls4 have an increased risk of gestational diabetes.6 Long-term follow-up is needed to assess whether the lower birth weights among the infants in the intervention group will translate into reduced rates of these later complications.
Despite the increased rate of admission to the neonatal nursery in the intervention group, there were no significant differences between the groups of infants in secondary clinical outcomes, such as hypoglycemia requiring intravenous therapy. As compared with the women in the routine-care group, the women in the intervention group made more visits to the medical clinic and were more likely to see a dietitian and diabetes educator. However, they made fewer antenatal clinic visits, a difference that was most likely related to their increased likelihood of induction and their infants' earlier gestational age at birth. The reduction in the risk of preeclampsia in the intervention group may be related to the earlier gestational age at birth.
A potentially controversial aspect of our study design from an ethical standpoint was the fact that women were not informed of their diagnosis of “gestational diabetes” during the course of the study, after the change in the WHO criteria. However, despite changes in the nomenclature for gestational diabetes,1,19,20 there continued to be no conclusive evidence regarding the effects of treatment of gestational diabetes17,18 and there were wide variations in clinical practice during the time of this study.22 Women in the study received standard pregnancy care consistent with care in which screening for gestational diabetes is not routine.
Our trial also revealed an improved health-related quality of life among women in the intervention group, both during the antenatal period and three months after birth, together with a reduction in the incidence of depression after birth. These findings are contrary to reports suggesting a decline in women's perception of their own health after they receive a diagnosis of gestational diabetes.31,32 However, results for these outcomes should be interpreted with caution, since the analysis included only a subgroup of the women.
There has been a lack of data from large randomized clinical trials on the effects of screening and treatment of women with gestational diabetes mellitus. An observational study is currently in progress to assess associations between maternal glucose levels and perinatal outcomes,20 and an ongoing randomized trial in the United States is addressing the effect of therapy for mild gestational diabetes, as did our study.33 Our results indicate that treatment of gestational diabetes in the form of dietary advice, blood glucose monitoring, and insulin therapy as required for glycemic control reduces the rate of serious perinatal complications, without increasing the rate of cesarean delivery.
Funded by two three-year project grants from the National Health and Medical Research Council Australia, the Queen Victoria Hospital Research Foundation, Adelaide, and supported by the Department of Obstetrics and Gynaecology at the University of Adelaide, South Australia.
We are indebted to the women and their children who participated in this study.
Source Information
From the Departments of Obstetrics and Gynaecology (C.A.C., J.S.R.) and Public Health (J.E.H., J.R.M.), University of Adelaide; the Department of Perinatal Medicine, Women's and Children's Hospital (A.J.M.); and the Department of Medicine, Lyell McEwin Health Service (W.S.J.) — all in Adelaide, Australia.
Members of the ACHOIS Trial Group are listed in the Appendix.
Appendix
The following persons and institutions participated in the ACHOIS Trial Group: Coordinating Team: C. Crowther, J. Hiller, J. Moss, A. McPhee, W. Jeffries, J. Robinson, A. Thomas, S. Alton, I. Flight, J. Hayton, A. Deussen, E. Griffith, S. Russell, S. Gibbons, C. Holst, K. Robinson; Steering Group: C. Crowther, J. Hiller, J. Moss, A. McPhee, W. Jeffries, J. Robinson; Statistical Support: K. Willson; Data-Monitoring Committee: J. Lumley (chair), L. Watson; Writing Group: C. Crowther, J. Hiller, J. Moss, A. McPhee, W. Jeffries, J. Robinson; Data Support: S. Brown, K. Bruggemann, P. Moore; Hospitals (total number of women recruited at each hospital is given in parentheses): Blacktown District Hospital, New South Wales (79): D. Chipps, R. Myszka, S. Hendon, M. McLean, H. Merker, J. Bradford; Bradford Royal Infirmary Maternity Unit, United Kingdom (0): D. Tuffnell, J. West; Caboolture Hospital, Queensland (28): M. Ratnapala, R. Hinton, D. Woodford, D. Cave, C. Armstrong, A. Vacca, P. Joubert, S. Mego, V. Heazelwood; Campbelltown Hospital, Sydney, New South Wales (1): H. Grunstein, S. Fleming, B. Marney; Flinders Medical Center, Adelaide, South Australia (43): K. Harris, J. Ebert, R. Bryce, S. Judd, M. Keirse, C. Verco; General Infirmary, Leeds, United Kingdom (3): E. Ferriman, G. Mason, C. Lidelle-Johnson, J. Pearce; Hammersmith Hospital, London (2): M. de Swiet, A. McCarthy; Hervey Bay Hospital, Queensland (24): A. Lindberg, D. Ludwig, K. Wickremachandran; Lyell McEwin Hospital, Adelaide, South Australia (125): G. Dekker, P. Duggan, I. Hocking, W. Jeffries, S. Kennedy-Andrews, N. Kretschmer, H. Millar, J. Mowbray; Modbury Hospital, Adelaide, South Australia (68): C. Archer, C. Hughes, G. Matthews, M. Morton, N. Price, L. Purins, N. Tamlin, J. Sieben; Nambour General Hospital, Queensland (37): C. Cocks, M. Gregora, S. Hamwood, G. Pinn, C. Rutherford, C. Sheehan, T. Stubbs, V. Smith-Orr; Northern General Hospital, Sheffield, United Kingdom (41): S. Rutter, C. Bruce, R. Fraser; Queen Elizabeth Hospital, Adelaide, South Australia (29): B. Pridmore (deceased), W. Hague, P. Phillips, M. Sladek, S. Torr; Royal North Shore Hospital, Sydney (198): G. Burton, R. Hitchman, I. Kelso, A. McElduff, J. Morris; St. George Hospital, Sydney (1): C. Homer, G. Davis; Toowoomba Base Hospital, Queensland (11): P. Bridger, Y. Chadha, D. Gibson, M. Ratnapala; Townsville Hospital, Queensland (48): D. Watson, A. Rane, A. Robinson, J. Whitehall, S. Dunstone, R. Chadwick, A. Dederer, A. Lawrence; Women's and Children's Hospital, South Australia (261): C. Crowther, R. Burnet, A. McPhee, J. Robinson, A. Thomas, S. Alton, J. Hayton, J. Paynter, A. Deussen, J. Avery, S. Agett, D. Morris, B. Peat, C. Wilkinson, V. Coppinger, J. Dodd.
- References
References
1
Hoffman L ,Nolan C ,Wilson JD ,Oats J ,Simmons D . Gestational diabetes mellitus -- management guidelines: the Australasian Diabetes in Pregnancy Society. Med J Aust 1998;169:93-97
Web of Science | Medline2
Clinical management guidelines for obstetrician-gynecologists. ACOG practice bulletin no. 30. Washington, D.C.: American College of Obstetricians and Gynecologists, 2001.
3
Blank A ,Grave G ,Metzger BE . Effects of gestational diabetes on perinatal morbidity reassessed: report of the International Workshop on Adverse Perinatal Outcomes of Gestational Diabetes Mellitus, December 3-4, 1992. Diabetes Care 1995;18:127-129
Web of Science | Medline4
Silverman B ,Metzger BE ,Cho NH ,Loeb CA . Impaired glucose tolerance in adolescent offspring of diabetic mothers: relationship to fetal hyperinsulinism. Diabetes Care 1995;18:611-617
CrossRef | Web of Science | Medline5
Petitt D ,Bennett PH ,Knowler WC ,Baird HR ,Aleck KA . Gestational diabetes mellitus and impaired glucose tolerance during pregnancy: long-term effects on obesity and glucose intolerance in the offspring. Diabetes Care 1985;34:Suppl 2:119-1226
Innes KE ,Byers TE ,Marshall JA ,Baron A ,Orleans M ,Hamman RF . Association of a woman's own birth weight with subsequent risk for gestational diabetes. JAMA 2002;287:2534-2541[Erratum, JAMA 2002;287:3212.]
CrossRef | Web of Science | Medline7
Rizzo TA ,Metzger BE ,Dooley SL ,Cho NH . Early malnutrition and child neurobehavioural development: insights from the study of children of diabetic mothers. Child Dev 1997;68:26-38
CrossRef | Web of Science | Medline8
O'Sullivan J. The Boston Gestational Diabetes Studies. In: Sutherland HW, Stowers JM, Pearson DWM, eds. Carbohydrate metabolism in pregnancy and the newborn. London: Springer-Verlag, 1989:287-94.
9
Metzger B ,Coustan D . Summary and recommendations of the Fourth International Workshop-Conference on Gestational Diabetes Mellitus. Diabetes Care 1998;21:Suppl 2:B161-B167
Web of Science | Medline10
American Diabetes Association
CrossRef11
Canadian Task Force on the Periodic Health Examination
Web of Science12
Screening for diabetes mellitus. In: Preventative Services Task Force. Guide to clinical preventive services: report of the U.S. Preventive Services Task Force. 2nd ed. Baltimore: Williams & Wilkins, 1996:193-208.
13
Scott DA ,Loveman E ,McIntyre L ,Waugh N . Screening for gestational diabetes: a systematic review and economic evaluation. Health Technol Assess 2002;6:1-161
CrossRef | Medline14
CG6 antenatal care: routine care for the healthy pregnant women — NICE guideline. London: National Institute for Clinical Excellence, 2003. (Accessed May 20, 2005, at http://www.nice.org.uk/page.aspx?o=89893.)
15
Hunter JS, Keirse MJNC. Gestational diabetes. In: Enkin M, Chalmers I, Keirse MJNC, eds. Effective care in pregnancy and childbirth. Oxford, England: Oxford University Press, 1989:403-10.
16
Scott DA ,Loveman E ,McIntyre L ,Waugh N . Screening for gestational diabetes. Health Technol Assess 2002;6:36-3617
Brody SC, Harris RH, Whitener BL, et al. Screening for gestational diabetes: systematic evidence review. Rockville, Md.: Agency for Healthcare Research and Quality, 2003.
18
Tuffnell DJ ,West J ,Walkinshaw SA . Treatments for gestational diabetes and impaired glucose tolerance in pregnancy. Cochrane Database Syst Rev 2003;3:CD003395-CD003395
Medline19
Diabetes mellitus: report of a WHO study group. World Health Organ Tech Rep Ser 1985;727:1-113
Medline20
Alberti KG ,Zimmet PZ . Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus: provisional report of a WHO consultation. Diabet Med 1998;15:539-553
CrossRef | Web of Science | Medline21
HAPO Study Cooperative Research Group
CrossRef | Web of Science | Medline22
Rumbold AR ,Crowther CA . Guideline use for gestational diabetes mellitus and current screening, diagnostic and management practices in Australian hospitals. Aust N Z J Obstet Gynaecol 2001;41:86-90
CrossRef | Web of Science | Medline23
Ware JE Jr ,Sherbourne CD . The MOS 36-Item Short-Form Health Survey (SF-36). I. Conceptual framework and item selection. Med Care 1992;30:473-483
CrossRef | Web of Science | Medline24
Marteau TM ,Bekker H . The development of a six-item short-form of the state scale of the Spielberger State-Trait Anxiety Inventory (STAI). Br J Clin Psychol 1992;31:301-306
CrossRef | Web of Science | Medline25
Cox JL ,Holden JM ,Sagovsky R . Detection of postnatal depression: development of the 10-item Edinburgh Postnatal Depression Scale. Br J Psychiatry 1987;150:782-786
CrossRef | Web of Science | Medline26
Altman DG . Confidence intervals for the number needed to treat. BMJ 1998;317:1309-1312
CrossRef | Web of Science | Medline27
Brazier J ,Roberts J ,Deverill M . The estimation of a preference-based measure of health from the SF-36. J Health Econ 2002;21:271-292
CrossRef | Web of Science | Medline28
Hochberg Y, Tamhane AC. Multiple comparison procedures. New York: John Wiley, 1987.
29
Chan A, Scott J, McCaul K, Keane R. Pregnancy outcome in South Australia 1992. Adelaide: South Australian Health Commission, 1993.
30
Roberts CL ,Lancaster PA . Australian national birthweight percentiles by gestational age. Med J Aust 1999;170:114-118
Web of Science | Medline31
Kerbel D ,Glazier R ,Holzapfel S ,Yeung M ,Lofsky S . Adverse effects of screening for gestational diabetes: a prospective cohort study in Toronto, Canada. J Med Screen 1997;4:128-132
Medline32
Rumbold AR ,Crowther CA . Women's experiences of being screened for gestational diabetes mellitus. Aust N Z J Obstet Gynaecol 2002;42:131-137
CrossRef | Web of Science | Medline33
Landon MB ,Thom E ,Spong CY , et al. A planned randomized clinical trial of treatment for mild gestational diabetes mellitus. J Matern Fetal Neonatal Med 2002;11:226-231
CrossRef | Medline
- Citing Articles (378)
Citing Articles
1
Nilmini Wickramasinghe, Indrit Troshani, Sally Rao Hill, William Hague, Steve Goldberg. (2013) A Transaction Cost Assessment of a Pervasive Technology Solution for Gestational Diabetes. International Journal of Healthcare Information Systems and Informatics 6:4, 60-76
CrossRef2
Deborah L. Conway. 2012. Gestational Diabetes Mellitus. , 168-173.
CrossRef3
M Makgoba, MD Savvidou, PJ Steer. (2012) An analysis of the interrelationship between maternal age, body mass index and racial origin in the development of gestational diabetes mellitus. BJOG: An International Journal of Obstetrics & Gynaecology 119:3, 276-282
CrossRef4
Shanshan Han, Caroline A Crowther, Philippa Middleton, Shanshan Han. 2012. Interventions for pregnant women with hyperglycaemia not meeting gestational diabetes and type 2 diabetes diagnostic criteria. .
CrossRef5
K. J. Hunt, N. M. Marlow, M. Gebregziabher, C. N. Ellerbe, J. Mauldin, M. E. Mayorga, J. E. Korte. (2012) Impact of maternal diabetes on birthweight is greater in non-Hispanic blacks than in non-Hispanic whites. Diabetologia
CrossRef6
George Attilakos, Timothy G. Overton. 2012. Antenatal Care. , 42-49.
CrossRef7
Anne Dornhorst, Catherine Williamson. 2012. Diabetes and Endocrine Disease in Pregnancy. , 121-136.
CrossRef8
Erica K. Berggren, Kim A. Boggess, Michele Jonsson Funk, Alison M. Stuebe. (2012) Racial Disparities in Perinatal Outcomes Among Women with Gestational Diabetes. Journal of Women's Health120104062612009
CrossRef9
Heather D Clark, Erin Keely. (2012) Getting mothers with gestational diabetes to return for postpartum testing: what works and what does not. Diabetes Management 2:1, 33-39
CrossRef10
Wendela L. de Ranitz-Greven, Dieuwke C. Bos, Wendy K. Poucki, Gerard H.A. Visser, Joline W.J. Beulens, Douwe H. Biesma, Harold W. de Valk. (2012) Advanced Glycation End Products, Measured as Skin Autofluorescence, at Diagnosis in Gestational Diabetes Mellitus Compared with Normal Pregnancy. Diabetes Technology & Therapeutics 14:1, 43-49
CrossRef11
Aidan McElduff, Robert G. Moses. (2012) Insulin Therapy in Pregnancy. Endocrinology & Metabolism Clinics of North America
CrossRef12
T. T. Lao, Daljit S. Sahota, S. S. H. Suen, L. W. Law, T. Y. Leung. (2012) Maternal HBsAg status and infant size - a Faustian bargain?. Journal of Viral Hepatitisno-no
CrossRef13
Warren Clayton, Neena Agarwal, Li Wang, Shubhada Jagasia. (2012) Clinical Markers Implying the Need for Treatment in Patients with Gestational Diabetes. Endocrine Practice 1:-1, 1-11
CrossRef14
Enrique Reyes-Muñoz, Adalberto Parra, Alfredo Castillo-Mora, Carlos Ortega-González. (2012) Impact of the International Association of Diabetes and Pregnancy Study Groups diagnostic criteria on the prevalence of gestational diabetes mellitus in urban Mexican women: A cross-sectional study. Endocrine Practice 1:-1, 1-17
CrossRef15
Jane E. Anderson. (2012) Complications of Labor and Delivery: Shoulder Dystocia. Primary Care: Clinics in Office Practice
CrossRef16
YW Cheng, TN Sparks, RK Laros Jr, JM Nicholson, AB Caughey. (2012) Impending macrosomia: will induction of labour modify the risk of caesarean delivery?. BJOG: An International Journal of Obstetrics & Gynaecologyno-no
CrossRef17
M van Leeuwen, MD Louwerse, BC Opmeer, J Limpens, MJ Serlie, JB Reitsma, BWJ Mol. (2012) Glucose challenge test for detecting gestational diabetes mellitus: a systematic review. BJOG: An International Journal of Obstetrics & Gynaecologyno-no
CrossRef18
Jerasimos Ballas, Thomas R. Moore, Gladys A. Ramos. (2011) Management of Diabetes in Pregnancy. Current Diabetes Reports
CrossRef19
Goran G. Babic, Slobodan S. Novokmet, Slobodan M. Jankovic. (2011) Changes of platelets’ function in preeclampsia. Central European Journal of Medicine 6:6, 696-700
CrossRef20
Caren G. Solomon, Ellen W. Seely. (2011) Hypertension in Pregnancy. Endocrinology & Metabolism Clinics of North America 40:4, 847-863
CrossRef21
Mark B. Landon, Steven G. Gabbe. (2011) Gestational Diabetes Mellitus. Obstetrics & Gynecology 118:6, 1379-1393
CrossRef22
Loralei L. Thornburg. (2011) Antepartum Obstetrical Complications Associated with Obesity. Seminars in Perinatology 35:6, 317-323
CrossRef23
David R. McCance. (2011) Pregnancy and diabetes. Best Practice & Research Clinical Endocrinology & Metabolism 25:6, 945-958
CrossRef24
Preeti Gandhi, Rebecca Bustani, Priya Madhuvrata, Tom Farrell. (2011) Introduction of metformin for gestational diabetes mellitus in clinical practice: has it had an impact?. European Journal of Obstetrics & Gynecology and Reproductive Biology
CrossRef25
Ann E. Evensen. (2011) Update on Gestational Diabetes Mellitus. Primary Care: Clinics in Office Practice
CrossRef26
A. K. Jenum, K. Morkrid, L. Sletner, S. Vangen, J. L. Torper, B. Nakstad, N. Voldner, O. H. Rognerud-Jensen, S. Berntsen, A. Mosdol, T. Skrivarhaug, M. H. Vardal, I. Holme, C. S. Yajnik, K. I. Birkeland. (2011) Gestational diabetes with the WHO and modified International Association of Diabetes and Pregnancy Study Groups criteria: Impact of ethnicity. A population-based cohort study.. European Journal of Endocrinology
CrossRef27
S. Al-Qahtani, A. Heath, S. Quenby, F. Dawood, R. Floyd, T. Burdyga, S. Wray. (2011) Diabetes is associated with impairment of uterine contractility and high Caesarean section rate. Diabetologia
CrossRef28
William W. Hay. (2011) Care of the Infant of the Diabetic Mother. Current Diabetes Reports
CrossRef29
Peter Damm, Louise Kelstrup, Elisabeth R. Mathiesen, Tine Dalsgaard Clausen. 2011. 13 Perinatal programming in offspring of diabetic mothers: Clinical data. , 141-152.
CrossRef30
Ebru Tarim, Tayfun Cok. (2011) Macrosomia prediction using different maternal and fetal parameters in women with 50 g glucose challenge test between 130 and 140 mg/dl. Archives of Gynecology and Obstetrics 284:5, 1081-1085
CrossRef31
Anita J. Gagnon, Sarah McDermott, Juliana Rigol-Chachamovich, Mridula Bandyopadhyay, Babill Stray-Pedersen, Donna Stewart, . (2011) International migration and gestational diabetes mellitus: a systematic review of the literature and meta-analysis. Paediatric and Perinatal Epidemiology 25:6, 575-592
CrossRef32
EVA ANDERBERG, MONA LANDIN-OLSSON, JOHAN KALÉN, ANDERS FRID, DAG URSING, KERSTIN BERNTORP. (2011) Prevalence of impaired glucose tolerance and diabetes after gestational diabetes mellitus comparing different cut-off criteria for abnormal glucose tolerance during pregnancy. Acta Obstetricia et Gynecologica Scandinavica 90:11, 1252-1258
CrossRef33
Jane E. Norman, Rebecca Reynolds. (2011) The consequences of obesity and excess weight gain in pregnancy. Proceedings of the Nutrition Society 70:04, 450-456
CrossRef34
Fiona C. Denison, Carolyn Chiswick. (2011) Improving pregnancy outcome in obese women. Proceedings of the Nutrition Society 70:04, 457-464
CrossRef35
Nicolai Lohse, Elliot Marseille, James G. Kahn. (2011) Development of a model to assess the cost-effectiveness of gestational diabetes mellitus screening and lifestyle change for the prevention of type 2 diabetes mellitus. International Journal of Gynecology & Obstetrics 115, S20-S25
CrossRef36
H. David McIntyre, Jeremy J.N. Oats, Willibald Zeck, V. Seshiah, Moshe Hod. (2011) Matching diagnosis and management of diabetes in pregnancy to local priorities and resources: An international approach. International Journal of Gynecology & Obstetrics 115, S26-S29
CrossRef37
Luis Cabero Roura, Moshe Hod, Anil Kapur, Nicolai Lohse. (2011) From biology to policy: The link between maternal health and current and future burden of chronic noncommunicable disease. International Journal of Gynecology & Obstetrics 115, S1-S2
CrossRef38
Nicky Lieberman, Ofra Kalter-Leibovici, Moshe Hod. (2011) Global adaptation of IADPSG recommendations: A national approach. International Journal of Gynecology & Obstetrics 115, S45-S47
CrossRef39
A. Dhanya Mackeen, Patrice M. L. Trauffer. 2011. Gestational diabetes. , 47-54.
CrossRef40
Melissa I. March, Suneet P. Chauhan. 2011. Fetal macrosomia. , 345-347.
CrossRef41
Abhishek Maiti, Koushik Nandi, Sudip Chatterjee. (2011) Management of gestational diabetes mellitus in a public hospital setting in India: Lessons from a minimalist approach. Diabetes Research and Clinical Practice
CrossRef42
Erin Kate Dooley, Robert L. Ringler. (2011) Prenatal Care: Touching the Future. Primary Care: Clinics in Office Practice
CrossRef43
J. Weichert, K. Diedrich, D.R. Hartge. (2011) Maternale Adipositas. Der Gynäkologe
CrossRef44
Shannon D. Sullivan, Jason G. Umans, Robert Ratner. (2011) Gestational Diabetes: Implications for Cardiovascular Health. Current Diabetes Reports
CrossRef45
Diane Farrar, Lelia Duley, Debbie A Lawlor, Diane Farrar. 2011. Different strategies for diagnosing gestational diabetes to improve maternal and infant health. .
CrossRef46
Mary Carolan, Mary-Ann Davey, Mary Anne Biro, Michelle Kealy. (2011) Maternal age, ethnicity and gestational diabetes mellitus. Midwifery
CrossRef47
S. Khattab, I. A. Mohsen, I. Aboul Foutouh, H. S. Ashmawi, M. N. Mohsen, M. van Wely, F. van der Veen, M. Af. Youssef. (2011) Can metformin reduce the incidence of gestational diabetes mellitus in pregnant women with polycystic ovary syndrome? Prospective cohort study. Gynecological Endocrinology 27:10, 789-793
CrossRef48
A. Lechner, R. Lohr, J. Seissler. (2011) Gestationsdiabetes. Der Internist 52:10, 1149-1157
CrossRef49
V. Balaji, Madhuri Balaji, C. Anjalakshi, A. Cynthia, T. Arthi, V. Seshiah. (2011) Inadequacy of fasting plasma glucose to diagnose gestational diabetes mellitus in Asian Indian women. Diabetes Research and Clinical Practice 94:1, e21-e23
CrossRef50
E.G. Simon, C.J. Fouché, F. Perrotin. (2011) Introduction à la méthodologie des essais randomisés : le choix du critère de jugement. Gynécologie Obstétrique & Fertilité 39:10, 595-596
CrossRef51
Vincent W. WONG, Bin JALALUDIN. (2011) Gestational diabetes mellitus: Who requires insulin therapy?. Australian and New Zealand Journal of Obstetrics and Gynaecology 51:5, 432-436
CrossRef52
Preeti Gandhi, Tom Farrell. (2011) Gestational diabetes mellitus (GDM) screening in morbidly obese pregnant women. European Journal of Obstetrics & Gynecology and Reproductive Biology
CrossRef53
Sven Schneider, Nele Freerksen, Silke Röhrig, Birgit Hoeft, Holger Maul. (2011) Gestational diabetes and preeclampsia – Similar risk factor profiles?. Early Human Development
CrossRef54
A. Lapolla, M. G. Dalfrà, E. Ragazzi, A. P. De Cata, D. Fedele. (2011) New International Association of the Diabetes and Pregnancy Study Groups (IADPSG) recommendations for diagnosing gestational diabetes compared with former criteria: a retrospective study on pregnancy outcome. Diabetic Medicine 28:9, 1074-1077
CrossRef55
Mika S. Ohno, Teresa N. Sparks, Yvonne W. Cheng, Aaron B. Caughey. (2011) Treating mild gestational diabetes mellitus: a cost-effectiveness analysis. American Journal of Obstetrics and Gynecology 205:3, 282.e1-282.e7
CrossRef56
H. Long. (2011) Diagnosing gestational diabetes: can expert opinions replace scientific evidence?. Diabetologia 54:9, 2211-2213
CrossRef57
Irma Yehuda, Jamille Nagtalon-Ramos, Kimberly Trout. (2011) Fetal Growth Scans and Amniotic Fluid Assessments in Pregestational and Gestational Diabetes. Journal of Obstetric, Gynecologic, & Neonatal Nursing 40:5, 603-616
CrossRef58
Michal Dishi, Daniel A. Enquobahrie, Dejene F. Abetew, Chunfang Qiu, Carole B. Rudra, Michelle A. Williams. (2011) Age at menarche, menstrual cycle characteristics and risk of gestational diabetes. Diabetes Research and Clinical Practice 93:3, 437-442
CrossRef59
Erica K. Berggren, Kim A. Boggess, Alison M. Stuebe, Michele Jonsson Funk. (2011) National Diabetes Data Group vs Carpenter-Coustan criteria to diagnose gestational diabetes. American Journal of Obstetrics and Gynecology 205:3, 253.e1-253.e7
CrossRef60
Melinda K. MORRISON, Clare E. COLLINS, Julia M. LOWE. (2011) Dietetic practice in the management of gestational diabetes mellitus: A survey of Australian dietitians. Nutrition & Dietetics 68:3, 189-194
CrossRef61
Annunziata Lapolla, Nino Cristiano Chilelli, Maria Grazia Dalfrà. (2011) New IADPSG recommendations: impact on care for gestational diabetes. Diabetes Management 1:5, 497-508
CrossRef62
EA Masson, SW Lindow. (2011) Can we afford to implement the IADPSG criteria for gestational diabetes?. Practical Diabetes 28:7, 285-286
CrossRef63
J. M. Pauli, N. Raja-Khan, X. Wu, R. S. Legro. (2011) Current perspectives of insulin resistance and polycystic ovary syndrome. Diabetic Medicineno-no
CrossRef64
Helena J. TEEDE, Cheryce L. HARRISON, Wan T. TEH, Eldho PAUL, Carolyn A. ALLAN. (2011) Gestational diabetes: Development of an early risk prediction tool to facilitate opportunities for prevention. Australian and New Zealand Journal of Obstetrics and Gynaecologyno-no
CrossRef65
Özgür Yilmaz, Mert Küçük, Levent Kebapçilar, Tamer Altindag, Arif Yüksel, Hüseyin Oguz Yuvanç, Tuba Dal, Yusuf Savran. (2011) Macrophage migration-inhibitory factor is elevated in pregnant women with gestational diabetes mellitus. Gynecological Endocrinology1-4
CrossRef66
Shanshan Han, Caroline A Crowther, Philippa Middleton, Shanshan Han. 2011. Different types of dietary advice for women with gestational diabetes mellitus. .
CrossRef67
D. A. Ogunyemi, A. Fong, S. Rad, S. Fong, S. L. Kjos. (2011) Attitudes and practices of healthcare providers regarding gestational diabetes: results of a survey conducted at the 2010 meeting of the International Association of Diabetes in Pregnancy Study Group (IADPSG). Diabetic Medicine 28:8, 976-986
CrossRef68
Mridula BANDYOPADHYAY, Rhonda SMALL, Mary-Ann DAVEY, Jeremy J. N. OATS, Della A. FORSTER, Amanda AYLWARD. (2011) Lived experience of gestational diabetes mellitus among immigrant South Asian women in Australia. Australian and New Zealand Journal of Obstetrics and Gynaecology 51:4, 360-364
CrossRef69
Per Ovesen, Steen Rasmussen, Ulrik Kesmodel. (2011) Effect of Prepregnancy Maternal Overweight and Obesity on Pregnancy Outcome. Obstetrics & Gynecology 118:2, Part 1, 305-312
CrossRef70
J. C. P. KINGDOM, M. WALKER, L. K. PROCTOR, S. KEATING, P. S. SHAH, A. MCLEOD, J. KEUNEN, R. C. WINDRIM, J. M. DODD. (2011) Unfractionated heparin for second trimester placental insufficiency: a pilot randomized trial. Journal of Thrombosis and Haemostasis 9:8, 1483-1492
CrossRef71
P. Gillespie, C. O’Neill, G. Avalos, M. O’Reilly, F. Dunne, . (2011) The cost of universal screening for gestational diabetes mellitus in Ireland. Diabetic Medicine 28:8, 912-918
CrossRef72
Mamoru Morikawa, Kazutoshi Cho, Takashi Yamada, Takahiro Yamada, Rina Shono, Takahiro Koyama, Masamitsu Takeda, Ryutaro Nishida, Hisanori Minakami. (2011) Relationships between fetal growth and maternal body mass indices, plasma glucose level, and plasma insulin level in Japanese women with mildly impaired glucose tolerance. Journal of Obstetrics and Gynaecology Researchno-no
CrossRef73
Tim Cundy. (2011) Proposed new diagnostic criteria for gestational diabetes - a pause for thought?. Diabetic Medicineno-no
CrossRef74
Erica Grant, Girish P. Joshi. (2011) Glycemic control during labor and delivery: a survey of academic centers in the United States. Archives of Gynecology and Obstetrics
CrossRef75
Paquita Montaner, Joaquim Ripollés, Carme Pamies, Rosa Corcoy. (2011) Measurement of fasting ketonuria and capillary blood glucose after main meals in women with gestational diabetes mellitus: How well is the metabolic picture captured?. Journal of Obstetrics and Gynaecology Research 37:7, 722-728
CrossRef76
Caroline H. D. Fall. (2011) Evidence for the intra-uterine programming of adiposity in later life. Annals of Human Biology 38:4, 410-428
CrossRef77
Lucilla Poston. (2011) Intergenerational transmission of insulin resistance and type 2 diabetes. Progress in Biophysics and Molecular Biology 106:1, 315-322
CrossRef78
Jodie G. Katon, Joan Russo, Amelia R. Gavin, Jennifer L. Melville, Wayne J. Katon. (2011) Diabetes and Depression in Pregnancy: Is There an Association?. Journal of Women's Health 20:7, 983-989
CrossRef79
, E. P. O’Sullivan, G. Avalos, M. O’Reilly, M. C. Dennedy, G. Gaffney, F. Dunne. (2011) Atlantic Diabetes in Pregnancy (DIP): the prevalence and outcomes of gestational diabetes mellitus using new diagnostic criteria. Diabetologia 54:7, 1670-1675
CrossRef80
Jessica A. Marcinkevage, K.M. Venkat Narayan. (2011) Gestational diabetes mellitus: Taking it to heart. Primary Care Diabetes 5:2, 81-88
CrossRef81
Christopher J Nolan, Peter Damm, Marc Prentki. (2011) Type 2 diabetes across generations: from pathophysiology to prevention and management. The Lancet 378:9786, 169-181
CrossRef82
Deborah L. Conway. 2011. Maternal Medical Conditions. , 117-131.
CrossRef83
H Ijäs, M Vääräsmäki, L Morin-Papunen, R Keravuo, T Ebeling, T Saarela, T Raudaskoski. (2011) Metformin should be considered in the treatment of gestational diabetes: a prospective randomised study. BJOG: An International Journal of Obstetrics & Gynaecology 118:7, 880-885
CrossRef84
Lisa Mirabello, Ruth Pfeiffer, Gwen Murphy, Najat C. Daw, Ana Patiño-Garcia, Rebecca J. Troisi, Robert N. Hoover, Chester Douglass, Joachim Schüz, Alan W. Craft, Sharon A. Savage. (2011) Height at diagnosis and birth-weight as risk factors for osteosarcoma. Cancer Causes & Control 22:6, 899-908
CrossRef85
Handan Kurtbas, H. Levent Keskin, A. Filiz Avsar. (2011) Effectiveness of screening for gestational diabetes during the late gestational period among pregnant Turkish women. Journal of Obstetrics and Gynaecology Research 37:6, 520-526
CrossRef86
Samira Behboudi Gandevani, Ahia Garshasbi, Shiva Dibaj. (2011) Cut-off value of 1-h, 50-g glucose challenge test for screening of gestational diabetes mellitus in an Iranian population. Journal of Obstetrics and Gynaecology Research 37:6, 534-537
CrossRef87
Patrick M. Catalano, Sylvie Hauguel-De Mouzon. (2011) Is it time to revisit the Pedersen hypothesis in the face of the obesity epidemic?. American Journal of Obstetrics and Gynecology 204:6, 479-487
CrossRef88
Gladys A. Ramos, Alethea A. Hanley, Jennifer Aguayo, Carri R. Warshak, Jae H. Kim, Thomas R. Moore. (2011) Neonatal chemical hypoglycemia in newborns from pregnancies complicated by type 2 and gestational diabetes mellitus – the importance of neonatal ponderal index. Journal of Maternal-Fetal and Neonatal Medicine1-5
CrossRef89
Sean C. Blackwell. (2011) Staying with old guidelines. American Journal of Obstetrics and Gynecology 204:5, 371-372
CrossRef90
Darcy B. Carr, Katherine M. Newton, Kristina M. Utzschneider, Mirjam V. Faulenbach, Steven E. Kahn, Thomas R. Easterling, Susan R. Heckbert. (2011) Gestational Diabetes or Lesser Degrees of Glucose Intolerance and Risk of Preeclampsia. Hypertension in Pregnancy 30:2, 153-163
CrossRef91
Joseph G. Ouzounian, Rachel Rosenheck, Richard H. Lee, Larisa Yedigarova, Carol L. Walden, Lisa M. Korst. (2011) One-hour post-glucola results and pre-pregnancy body mass index are associated with the need for insulin therapy in women with gestational diabetes. Journal of Maternal-Fetal and Neonatal Medicine 24:5, 718-722
CrossRef92
Dwight J. Rouse. (2011) Marry old and new guidelines. American Journal of Obstetrics and Gynecology 204:5, 371-372
CrossRef93
S. M. Lau, S. Lin, R. A. Stokes, K. Cheng, P. A. Baldock, R. F. Enriquez, M. McLean, N. W. Cheung, A. Sainsbury, F. J. Gonzalez, H. Herzog, J. E. Gunton. (2011) Synergistic effects of genetic beta cell dysfunction and maternal glucose intolerance on offspring metabolic phenotype in mice. Diabetologia 54:4, 910-921
CrossRef94
Andrew Symon, Ben Dobb. (2011) Maternal quality of life assessment: the feasibility of antenatal–postnatal follow‐up using the Mother‐Generated Index. Journal of Reproductive and Infant Psychology 29:2, 183-194
CrossRef95
R. I. G. Holt, M. A. Coleman, D. R. McCance. (2011) The implications of the new International Association of Diabetes and Pregnancy Study Groups (IADPSG) diagnostic criteria for gestational diabetes. Diabetic Medicine 28:4, 382-385
CrossRef96
Scarlett D Karakash, Francine H Einstein. (2011) Diabetes in pregnancy: glycemia control guidelines and rationale. Current Opinion in Endocrinology, Diabetes and Obesity 18:2, 99-103
CrossRef97
Michael J Paglia, Donald R Coustan. (2011) Gestational diabetes: evolving diagnostic criteria. Current Opinion in Obstetrics and Gynecology 23:2, 72-75
CrossRef98
Shanshan Han, Caroline A Crowther, Philippa Middleton, Shanshan Han. 2011. Interventions for pregnant women with hyperglycaemia not meeting gestational diabetes and type 2 diabetes diagnostic criteria. .
CrossRef99
A. Reeske, J. Spallek. (2011) Sozioökonomische Aspekte der Primärprävention von Adipositas bei Kindern und Jugendlichen. Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz 54:3, 272-280
CrossRef100
Ana Cristina Maymone, Jean-Patrice Baillargeon, Julie Ménard, Jean-Luc Ardilouze. (2011) Oral hypoglycemic agents for gestational diabetes mellitus?. Expert Opinion on Drug Safety 10:2, 227-238
CrossRef101
John R. McArdle. (2011) Pregnancy in Cystic Fibrosis. Clinics in Chest Medicine 32:1, 111-120
CrossRef102
J. Lepercq. (2011) Diabète gestationnel, surpoids, obésité. Revue de médecine périnatale 3:1, 5-10
CrossRef103
Manuel Usandizaga Calparsoro, Lucía Fernández-Repeto Nuche. (2011) La morbilidad de la histerectomía radical como variable de resultado combinada. Progresos de Obstetricia y Ginecología 54:3, 115-120
CrossRef104
Tania F. Esakoff, Aaron B. Caughey, Ingrid Block-Kurbisch, Maribeth Inturrisi, Yvonne W. Cheng. (2011) Perinatal outcomes in patients with gestational diabetes mellitus by race/ethnicity. Journal of Maternal-Fetal and Neonatal Medicine 24:3, 422-426
CrossRef105
E. A. Ryan. (2011) Diagnosing gestational diabetes. Diabetologia 54:3, 480-486
CrossRef106
H. Legardeur, G. Girard, L. Mandelbrot. (2011) Dépistage du diabète gestationnel : vers un nouveau consensus ?. Gynécologie Obstétrique & Fertilité 39:3, 174-179
CrossRef107
2011. Classification and Diagnosis. , 1-21.
CrossRef108
Marsha van Leeuwen, Brent C. Opmeer, Yildirim Yilmaz, Jacqueline Limpens, Mireille J. Serlie, Ben Willem J. Mol. (2011) Accuracy of the random glucose test as screening test for gestational diabetes mellitus: a systematic review. European Journal of Obstetrics & Gynecology and Reproductive Biology 154:2, 130-135
CrossRef109
R. S. Lindsay. (2011) Gestational diabetes: costs and consequences. Diabetologia 54:2, 227-229
CrossRef110
Surabhi Nanda, Mina Savvidou, Argyro Syngelaki, Ranjit Akolekar, Kypros H. Nicolaides. (2011) Prediction of gestational diabetes mellitus by maternal factors and biomarkers at 11 to 13 weeks. Prenatal Diagnosis 31:2, 135-141
CrossRef111
Wan T. TEH, Helena J. TEEDE, Eldho PAUL, Cheryce L. HARRISON, Euan M. WALLACE, Carolyn ALLAN. (2011) Risk factors for gestational diabetes mellitus: Implications for the application of screening guidelines. Australian and New Zealand Journal of Obstetrics and Gynaecology 51:1, 26-30
CrossRef112
Jenny HUYNH, Sujiva RATNAIKE, Catherine BARTALOTTA, Michael PERMEZEL, Christine HOULIHAN. (2011) Challenging the glucose challenge test. Australian and New Zealand Journal of Obstetrics and Gynaecology 51:1, 22-25
CrossRef113
Carol J. Homko. (2011) New Recommendations for the Diagnosis of Diabetes in Pregnancy. Current Diabetes Reports 11:1, 1-3
CrossRef114
Mark B. Landon, Lisa Mele, Catherine Y. Spong, Marshall W. Carpenter, Susan M. Ramin, Brian Casey, Ronald J. Wapner, Michael W. Varner, Dwight J. Rouse, John M. Thorp, Anthony Sciscione, Patrick Catalano, Margaret Harper, George Saade, Steve N. Caritis, Yoram Sorokin, Alan M. Peaceman, Jorge E. Tolosa, Garland D. Anderson. (2011) The Relationship Between Maternal Glycemia and Perinatal Outcome. Obstetrics & Gynecology 117:2, Part 1, 218-224
CrossRef115
J. A. Round, P. Jacklin, R. B. Fraser, R. G. Hughes, M. A. Mugglestone, R. I. G. Holt. (2011) Screening for gestational diabetes mellitus: cost–utility of different screening strategies based on a woman’s individual risk of disease. Diabetologia 54:2, 256-263
CrossRef116
David Simmons. (2011) Diabetes and obesity in pregnancy. Best Practice & Research Clinical Obstetrics & Gynaecology 25:1, 25-36
CrossRef117
LUCILLA POSTON, LUCIEN F. HARTHOORN, ELINE M. VAN DER BEEK. (2011) Obesity in Pregnancy: Implications for the Mother and Lifelong Health of the Child. A Consensus Statement. Pediatric Research 69:2, 175-180
CrossRef118
Lynn M. Yee, Yvonne W. Cheng, Jennifer Liddell, Ingrid Block-kurbisch, Aaron B. Caughey. (2011) 50-Gram glucose challenge test: is it indicative of outcomes in women without gestational diabetes mellitus?. Journal of Maternal-Fetal and Neonatal Medicine1-5
CrossRef119
2011. Part Introduction. , 33-280.
CrossRef120
Marie-Claude Battista, Marie-France Hivert, Karine Duval, Jean-Patrice Baillargeon. (2011) Intergenerational Cycle of Obesity and Diabetes: How Can We Reduce the Burdens of These Conditions on the Health of Future Generations?. Experimental Diabetes Research 2011, 1-19
CrossRef121
Alma Ethelia López Caudana, Ruy López Ridaura, Clicerio González Villalpando, Eduardo César Lazcano Ponce, Esther Margarita Casanueva y López, Mauricio Hernández Ávila, Martha María Téllez-Rojo Solís. (2011) Prediction of Alterations in Glucose Metabolism by Glucose and Insulin Measurements in Early Pregnancy. Archives of Medical Research 42:1, 70-76
CrossRef122
Camille E. Powe, Ravi Thadhani. (2011) Diabetes and the Kidney in Pregnancy. Seminars in Nephrology 31:1, 59-69
CrossRef123
Walter Plasencia, Raquel Garcia, Susana Pereira, Ranjit Akolekar, Kypros H. Nicolaides. (2011) Criteria for Screening and Diagnosis of Gestational Diabetes Mellitus in the First Trimester of Pregnancy. Fetal Diagnosis and Therapy 30:2, 108-115
CrossRef124
Robert G. Moses, Jennie C. Brand-Miller. (2011) The use of a low glycaemic index diet in pregnancy: An evolving treatment paradigm. Diabetes Research and Clinical Practice 91:1, 13-14
CrossRef125
Shannan M. Grant, Thomas M.S. Wolever, Deborah L. O’Connor, Rosane Nisenbaum, Robert G. Josse. (2011) Effect of a low glycaemic index diet on blood glucose in women with gestational hyperglycaemia. Diabetes Research and Clinical Practice 91:1, 15-22
CrossRef126
Kypros H. Nicolaides. (2011) Turning the Pyramid of Prenatal Care. Fetal Diagnosis and Therapy 29:3, 183-196
CrossRef127
J.M. Johanson, P.J. Berger, S. Tsuruta, I. Misztal. (2011) A Bayesian threshold-linear model evaluation of perinatal mortality, dystocia, birth weight, and gestation length in a Holstein herd. Journal of Dairy Science 94:1, 450-460
CrossRef128
Alice R Rumbold, Ross S Bailie, Damin Si, Michelle C Dowden, Catherine M Kennedy, Rhonda J Cox, Lynette O'Donoghue, Helen E Liddle, Ru K Kwedza, Sandra C Thompson, Hugh P Burke, Alex DH Brown, Tarun Weeramanthri, Christine M Connors. (2011) Delivery of maternal health care in Indigenous primary care services: baseline data for an ongoing quality improvement initiative. BMC Pregnancy and Childbirth 11:1, 16
CrossRef129
E. Kattner, F. Maier, M. Gonser, K.T.M. Schneider, F. Kainer, T. Somville, K. Vetter, U. Schäfer-Graf, K. Schunk, M. Mandl, I. Müller-Hansen, C. Bührer. (2011) Leitlinie zur Betreuung von Neugeborenen diabetischer Mütter. Monatsschrift Kinderheilkunde 159:1, 57-62
CrossRef130
Madiha Syed, Hasan Javed, Mohammad Yawar Yakoob, Zulfiqar A Bhutta. (2011) Effect of screening and management of diabetes during pregnancy on stillbirths. BMC Public Health 11:Suppl 3, S2
CrossRef131
Jodie M Dodd, Deborah A Turnbull, Andrew J McPhee, Gary Wittert, Caroline A Crowther, Jeffrey S Robinson. (2011) Limiting weight gain in overweight and obese women during pregnancy to improve health outcomes: the LIMIT randomised controlled trial. BMC Pregnancy and Childbirth 11:1, 79
CrossRef132
Andrea Leiva, Fabián Pardo, Marco A. Ramírez, Marcelo Farías, Paola Casanello, Luis Sobrevia. (2011) Fetoplacental Vascular Endothelial Dysfunction as an Early Phenomenon in the Programming of Human Adult Diseases in Subjects Born from Gestational Diabetes Mellitus or Obesity in Pregnancy. Experimental Diabetes Research 2011, 1-18
CrossRef133
N. D. Osgood, R. F. Dyck, W. K. Grassmann. (2011) The Inter- and Intragenerational Impact of Gestational Diabetes on the Epidemic of Type 2 Diabetes. American Journal of Public Health 101:1, 173-179
CrossRef134
Song Zhang, Leewen Rattanatray, Janna L. Morrison, Lisa M. Nicholas, Shervi Lie, I. Caroline McMillen. (2011) Maternal Obesity and the Early Origins of Childhood Obesity: Weighing Up the Benefits and Costs of Maternal Weight Loss in the Periconceptional Period for the Offspring. Experimental Diabetes Research 2011, 1-10
CrossRef135
S. Hiéronimus, J.-P. Le Meaux. (2010) Relevance of gestational diabetes mellitus screening and comparison of selective with universal strategies. Diabetes & Metabolism 36:6, 575-586
CrossRef136
C. Garabedian, P. Deruelle. (2010) Delivery (timing, route, peripartum glycemic control) in women with gestational diabetes mellitus. Diabetes & Metabolism 36:6, 515-521
CrossRef137
D. Mitanchez. (2010) Foetal and neonatal complications in gestational diabetes: perinatal mortality, congenital malformations, macrosomia, shoulder dystocia, birth injuries, neonatal complications. Diabetes & Metabolism 36:6, 617-627
CrossRef138
M Salmenhaara, L Uusitalo, U Uusitalo, C Kronberg-Kippilä, H Sinkko, S Ahonen, R Veijola, M Knip, M Kaila, S M Virtanen. (2010) Diet and weight gain characteristics of pregnant women with gestational diabetes. European Journal of Clinical Nutrition 64:12, 1433-1440
CrossRef139
G. Beucher, B. Viaris de Lesegno, M. Dreyfus. (2010) Maternal outcome of gestational diabetes mellitus. Diabetes & Metabolism 36:6, 522-537
CrossRef140
S. Jacqueminet, M.-F. Jannot-Lamotte. (2010) Therapeutic management of gestational diabetes. Diabetes & Metabolism 36:6, 658-671
CrossRef141
E. Cosson. (2010) Diagnostic criteria for gestational diabetes mellitus. Diabetes & Metabolism 36:6, 538-548
CrossRef142
D. Mitanchez. (2010) Management of infants born to mothers with gestational diabetes. Paediatric environment. Diabetes & Metabolism 36:6, 587-594
CrossRef143
A. Burguet. (2010) Long-term outcome in children of mothers with gestational diabetes. Diabetes & Metabolism 36:6, 682-694
CrossRef144
C. Vayssière, H. Grandjean. (2010) Methods and organization. Diabetes & Metabolism 36:6, 512-514
CrossRef145
Mamoru Morikawa, Takashi Yamada, Takahiro Yamada, Rina Akaishi, Ryutaro Nishida, Kazutoshi Cho, Hisanori Minakami. (2010) Change in the number of patients after the adoption of IADPSG criteria for hyperglycemia during pregnancy in Japanese women. Diabetes Research and Clinical Practice 90:3, 339-342
CrossRef146
Eleni Anastasiou, Vasiliki Vasileiou, Anastasia Athanasiadou, Charalampos Stavrianos, Katerina Saltiki, Maria Alevizaki. (2010) Phenotypic and metabolic characteristics of women with isolated hyperglycemia in pregnancy—Is the time-point important?. Diabetes Research and Clinical Practice 90:3, 333-338
CrossRef147
T. L. Dailey, D. R. Coustan. (2010) Diabetes in Pregnancy. NeoReviews 11:11, e619-e626
CrossRef148
Joanna Tieu, Suzette Coat, William Hague, Philippa Middleton, Joanna Tieu. 2010. Oral anti-diabetic agents for women with pre-existing diabetes mellitus/impaired glucose tolerance or previous gestational diabetes mellitus. .
CrossRef149
Donald R. Coustan. (2010) Diabetes: Finding and treating gestational diabetes mellitus—does it help?. Nature Reviews Endocrinology 6:10, 540-542
CrossRef150
Jeff R. FLACK, Glynis P. ROSS, Suyen HO, Aidan McELDUFF. (2010) Recommended changes to diagnostic criteria for gestational diabetes: Impact on workload. Australian and New Zealand Journal of Obstetrics and Gynaecology 50:5, 439-443
CrossRef151
Eran Hadar, Moshe Hod. (2010) Establishing consensus criteria for the diagnosis of diabetes in pregnancy following the HAPO study. Annals of the New York Academy of Sciences 1205:1, 88-93
CrossRef152
A. Lapolla, M. Bonomo, M.G. Dalfrà, E. Parretti, D. Mannino, G. Mello, G. Di Cianni. (2010) Prepregnancy BMI influences maternal and fetal outcomes in women with isolated gestational hyperglycaemia: A multicentre study. Diabetes & Metabolism 36:4, 265-270
CrossRef153
Mary Carolan, Cheryl Steele, Heather Margetts. (2010) Attitudes towards gestational diabetes among a multiethnic cohort in Australia. Journal of Clinical Nursing 19:17-18, 2446-2453
CrossRef154
Clive J. Petry. (2010) Gestational diabetes: risk factors and recent advances in its genetics and treatment. British Journal of Nutrition 104:06, 775-787
CrossRef155
Norman Waugh, Donald Pearson, Pamela Royle. (2010) Screening for hyperglycaemia in pregnancy: Consensus and controversy. Best Practice & Research Clinical Endocrinology & Metabolism 24:4, 553-571
CrossRef156
Helen Barrett, Aidan McElduff. (2010) Vitamin D and pregnancy: An old problem revisited. Best Practice & Research Clinical Endocrinology & Metabolism 24:4, 527-539
CrossRef157
Haiju H. Chirayath, Mark Wareing, Michael J. Taggart, Philip N. Baker. (2010) Endothelial dysfunction in myometrial arteries of women with gestational diabetes. Diabetes Research and Clinical Practice 89:2, 134-140
CrossRef158
Carol J. Homko. (2010) Gestational Diabetes Mellitus: Can We Reach Consensus?. Current Diabetes Reports 10:4, 252-254
CrossRef159
P. M. Catalano. (2010) The impact of gestational diabetes and maternal obesity on the mother and her offspring. Journal of Developmental Origins of Health and Disease 1:04, 208-215
CrossRef160
Joyce Leary, David J. Pettitt, Lois Jovanovič. (2010) Gestational diabetes guidelines in a HAPO world. Best Practice & Research Clinical Endocrinology & Metabolism 24:4, 673-685
CrossRef161
2010. Pregnancy and Diabetes. , 201-208.
CrossRef162
Anne Dornhorst, Anita Banerjee. 2010. Diabetes in Pregnancy. , 888-921.
CrossRef163
Monika Toeller. 2010. Lifestyle Issues: Diet. , 346-357.
CrossRef164
Joanna Tieu, Philippa Middleton, Andrew J McPhee, Caroline A Crowther, Joanna Tieu. 2010. Screening and subsequent management for gestational diabetes for improving maternal and infant health. .
CrossRef165
Mark B. Landon, Steven G. Gabbe. 2010. Diabetes Mellitus. , 228-236.
CrossRef166
Carolina Reyes. 2010. Diabetes Mellitus in Pregnancy. , 135-140.
CrossRef167
Michael F. Greene, Caren G. Solomon, Stephanie L. Lee, Robert A. Peterfreund. 2010. Diabetes Mellitus in Pregnancy. , 293-321.
CrossRef168
Mark B. Landon. (2010) Is there a benefit to the treatment of mild gestational diabetes mellitus?. American Journal of Obstetrics and Gynecology 202:6, 649-653
CrossRef169
Juana A. Flores-Le Roux, Juan J. Chillaron, Alberto Goday, Jaume Puig De Dou, Antoni Paya, Maria A. Lopez-Vilchez, Juan F. Cano. (2010) Peripartum metabolic control in gestational diabetes. American Journal of Obstetrics and Gynecology 202:6, 568.e1-568.e6
CrossRef170
Thomas R. Moore. (2010) Fetal exposure to gestational diabetes contributes to subsequent adult metabolic syndrome. American Journal of Obstetrics and Gynecology 202:6, 643-649
CrossRef171
S. McClean, D. Farrar, C. A. Kelly, D. J. Tuffnell, D. C. Whitelaw. (2010) The importance of postpartum glucose tolerance testing after pregnancies complicated by gestational diabetes. Diabetic Medicine 27:6, 650-654
CrossRef172
Gabriella Pridjian, Tara D. Benjamin. (2010) Update on Gestational Diabetes. Obstetrics and Gynecology Clinics of North America 37:2, 255-267
CrossRef173
Donald R. Coustan, Lynn P. Lowe, Boyd E. Metzger, Alan R. Dyer. (2010) The Hyperglycemia and Adverse Pregnancy Outcome (HAPO) study: paving the way for new diagnostic criteria for gestational diabetes mellitus. American Journal of Obstetrics and Gynecology 202:6, 654.e1-654.e6
CrossRef174
Antonio Desmond McCarthy, Renata Curciarello, Nicolás Castiglione, Marina Fernández Tayeldín, Diego Costa, Verónica Arnol, Anabela Prospitti, Analía Aliano, Daniela Archuby, Augusto Graieb, María J. Torres, Susana B. Etcheverry, María C. Apezteguía. (2010) Universal versus selective screening for the detection, control and prognosis of gestational diabetes mellitus in Argentina. Acta Diabetologica 47:2, 97-103
CrossRef175
T. Harder, A. Plagemann, A. Harder. (2010) Birth weight and risk of neuroblastoma: a meta-analysis. International Journal of Epidemiology 39:3, 746-756
CrossRef176
Wadia R. Mulla, Tasmia Q. Henry, Carol J. Homko. (2010) Gestational Diabetes Screening After HAPO: Has Anything Changed?. Current Diabetes Reports 10:3, 224-228
CrossRef177
Laura J. Rasmussen-Torvik, Bernard L. Harlow. (2010) The Association Between Depression and Diabetes in the Perinatal Period. Current Diabetes Reports 10:3, 217-223
CrossRef178
S. M. Nelson, P. Matthews, L. Poston. (2010) Maternal metabolism and obesity: modifiable determinants of pregnancy outcome. Human Reproduction Update 16:3, 255-275
CrossRef179
Jean-Luc Ardilouze, Masoud Mahdavian, Jean-Patrice Baillargeon. (2010) Brick by brick: metformin for gestational diabetes mellitus?. Expert Review of Endocrinology & Metabolism 5:3, 353-357
CrossRef180
Ching-Yu Chou, Ching-Ling Lin, Chun-Kuang Yang, Wei-Chen Yang, Fa-Kung Lee, Ming-Song Tsai. (2010) Pregnancy Outcomes of Taiwanese Women with Gestational Diabetes Mellitus: A Comparison of Carpenter-Coustan and National Diabetes Data Group Criteria. Journal of Women's Health 19:5, 935-939
CrossRef181
T. Sathyapalan, D. Mellor, S.L. Atkin. (2010) Obesity and gestational diabetes. Seminars in Fetal and Neonatal Medicine 15:2, 89-93
CrossRef182
Kate J. Fitzsimons, J. Modder. (2010) Setting maternity care standards for women with obesity in pregnancy. Seminars in Fetal and Neonatal Medicine 15:2, 100-107
CrossRef183
Andreia David Sapienza, Rossana Pulcineli Vieira Francisco, Thatianne Coutheux Trindade, Marcelo Zugaib. (2010) Factors predicting the need for insulin therapy in patients with gestational diabetes mellitus. Diabetes Research and Clinical Practice 88:1, 81-86
CrossRef184
H. E. Fadl, I. K. M. Östlund, A. F. K. Magnuson, U. S. B. Hanson. (2010) Maternal and neonatal outcomes and time trends of gestational diabetes mellitus in Sweden from 1991 to 2003. Diabetic Medicine 27:4, 436-441
CrossRef185
David A. Sacks. 2010. Screening for Hyperglycemia in Pregnancy. , 45-56.
CrossRef186
Anita Banerjee, Anne Dornhorst. 2010. Diet and Exercise in Diabetes in Pregnancy. , 128-136.
CrossRef187
Michael Maresh. 2010. Obstetric Management of Labor, Delivery, and the Postnatal Period. , 197-210.
CrossRef188
Marshall W. Carpenter. 2010. Diagnosis of Hyperglycemia in Pregnancy. , 57-64.
CrossRef189
David Simmons. 2010. Epidemiologic Context of Diabetes in Pregnancy. , 1-16.
CrossRef190
Robert Fraser. 2010. Rationale for Treatment of Hyperglycemia in Pregnancy. , 65-74.
CrossRef191
Guanghui Li, Ling Fan, Li Zhang, Weiyuan Zhang, Xinghua Huang. (2010) Metabolic parameters and perinatal outcomes of gestational diabetes mellitus in women with polycystic ovary syndrome. Journal of Perinatal Medicine 38:2, 141-146
CrossRef192
SJ Meltzer, J Snyder, JR Penrod, M Nudi, L Morin. (2010) Gestational diabetes mellitus screening and diagnosis: a prospective randomised controlled trial comparing costs of one-step and two-step methods. BJOG: An International Journal of Obstetrics & Gynaecology 117:4, 407-415
CrossRef193
(2010) Hyperglycemia and Adverse Pregnancy Outcome (HAPO) study: preeclampsia. American Journal of Obstetrics and Gynecology 202:3, 255.e1-255.e7
CrossRef194
Hubert Kolb, Kerstin Kempf, Stephan Martin, Michael Stumvoll, Rüdiger Landgraf. (2010) On what evidence-base do we recommend self-monitoring of blood glucose?. Diabetes Research and Clinical Practice 87:2, 150-156
CrossRef195
Chloe A. Zera, Ellen W. Seely. (2010) Diabetes: Treatment of gestational diabetes reduces obstetric morbidity. Nature Reviews Endocrinology 6:2, 69-70
CrossRef196
(2010) Treatment for Mild Gestational Diabetes. New England Journal of Medicine 362:4, 365-367
Full Text197
Cande V. Ananth, Olga Basso. (2010) Impact of Pregnancy-induced Hypertension on Stillbirth and Neonatal Mortality. Epidemiology 21:1, 118-123
CrossRef198
Jimmy Chun Yu Louie, Jennie C. Brand-Miller, Tania P. Markovic, Glynis P. Ross, Robert G. Moses. (2010) Glycemic Index and Pregnancy: A Systematic Literature Review. Journal of Nutrition and Metabolism 2010, 1-8
CrossRef199
Hyo-Jeong Kang, Hye-Min Kwak, Yong-Seok Kim, Jin-Sun Park, Gun Yoon, Suk-Joo Choi, Soo-Young Oh, Jong-Hwa Kim, Cheong-Rae Roh. (2010) Obstetric and neonatal outcomes after treatment of gestational diabetes mellitus class A1 and class A2. Korean Journal of Obstetrics and Gynecology 53:8, 681
CrossRef200
Gustaaf Dekker. 2010. Maternal disorders and stillbirth. , 25-42.
CrossRef201
M van Leeuwen, BC Opmeer, EJK Zweers, E van Ballegooie, HG ter Brugge, HW de Valk, GHA Visser, BWJ Mol. (2010) Estimating the risk of gestational diabetes mellitus: a clinical prediction model based on patient characteristics and medical history. BJOG: An International Journal of Obstetrics & Gynaecology 117:1, 69-75
CrossRef202
E Taricco, T Radaelli, G Rossi, MS Nobile de Santis, GP Bulfamante, L Avagliano, I Cetin. (2009) Effects of gestational diabetes on fetal oxygen and glucose levels in vivo. BJOG: An International Journal of Obstetrics & Gynaecology 116:13, 1729-1735
CrossRef203
Eva Mautner, Eva Greimel, Gerda Trutnovsky, Fedor Daghofer, Josef W. Egger, Uwe Lang. (2009) Quality of life outcomes in pregnancy and postpartum complicated by hypertensive disorders, gestational diabetes, and preterm birth. Journal of Psychosomatic Obstetrics & Gynecology 30:4, 231-237
CrossRef204
P. Deruelle. (2009)
3es rencontres médecins-chirurgiens 
sur la chirurgie de l’obésité Obésité et grossesse. Le point de vue de l’obstétricien. Obésité 4:3-4, 153-155
CrossRef205
David Simmons. (2009) Diabetes: Diabetes risk after gestational diabetes mellitus. Nature Reviews Endocrinology 5:12, 646-648
CrossRef206
Nir Melamed, Yariv Yogev. (2009) Can pregnant diabetics be treated with glyburide?. Women's Health 5:6, 649-658
CrossRef207
Shali Mazaki-Tovi, Roberto Romero, Edi Vaisbuch, Offer Erez, Pooja Mittal, Tinnakorn Chaiworapongsa, Sun Kwon Kim, Percy Pacora, Lami Yeo, Francesca Gotsch, Zhong Dong, Bo Hyun Yoon, Sonia S. Hassan, Juan Pedro Kusanovic. (2009) Maternal serum adiponectin multimers in gestational diabetes. Journal of Perinatal Medicine 37:6, 637-650
CrossRef208
F Ahlsson, M Lundgren, T Tuvemo, J Gustafsson, B Haglund. (2009) Gestational diabetes and offspring body disproportion. Acta Paediatrica
CrossRef209
Hong JU, Yogesh CHADHA, Tim DONOVAN, Peter O’ROURKE. (2009) Fetal macrosomia and pregnancy outcomes. Australian and New Zealand Journal of Obstetrics and Gynaecology 49:5, 504-509
CrossRef210
Sacks, David A., . (2009) Gestational Diabetes — Whom Do We Treat?. New England Journal of Medicine 361:14, 1396-1398
Full Text211
Landon, Mark B., Spong, Catherine Y., Thom, Elizabeth, Carpenter, Marshall W., Ramin, Susan M., Casey, Brian, Wapner, Ronald J., Varner, Michael W., Rouse, Dwight J., Thorp, John M. Jr., Sciscione, Anthony, Catalano, Patrick, Harper, Margaret, Saade, George, Lain, Kristine Y., Sorokin, Yoram, Peaceman, Alan M., Tolosa, Jorge E., Anderson, Garland B., . (2009) A Multicenter, Randomized Trial of Treatment for Mild Gestational Diabetes. New England Journal of Medicine 361:14, 1339-1348
Full Text212
Eran Hadar, Jeremy Oats, Moshe Hod. (2009) Towards new diagnostic criteria for diagnosing GDM – the HAPO study. Journal of Perinatal Medicine 37:5, 447-449
CrossRef213
Michael J. Paglia, Donald R. Coustan. (2009) The use of oral antidiabetic medications in gestational diabetes mellitus. Current Diabetes Reports 9:4, 287-290
CrossRef214
J. Balani, S. L. Hyer, D. A. Rodin, H. Shehata. (2009) Pregnancy outcomes in women with gestational diabetes treated with metformin or insulin: a case-control study. Diabetic Medicine 26:8, 798-802
CrossRef215
Annunziata Lapolla, Maria Grazia Dalfrà, Matteo Bonomo, Elena Parretti, Domenico Mannino, Giorgio Mello, Graziano Di Cianni. (2009) Gestational diabetes mellitus in Italy: A multicenter study. European Journal of Obstetrics & Gynecology and Reproductive Biology 145:2, 149-153
CrossRef216
Yvonne W. Cheng, Ingrid Block-Kurbisch, Aaron B. Caughey. (2009) Carpenter-Coustan Criteria Compared With the National Diabetes Data Group Thresholds for Gestational Diabetes Mellitus. Obstetrics & Gynecology 114:2, Part 1, 326-332
CrossRef217
Ravi Retnakaran, Ying Qi, Mathew Sermer, Philip W. Connelly, Anthony J. G. Hanley, Bernard Zinman. (2009) An abnormal screening glucose challenge test in pregnancy predicts postpartum metabolic dysfunction, even when the antepartum oral glucose tolerance test is normal. Clinical Endocrinology 71:2, 208-214
CrossRef218
Nisreen Alwan, Derek J Tuffnell, Jane West, Nisreen Alwan. 2009. Treatments for gestational diabetes. .
CrossRef219
M. van Leeuwen, B.C. Opmeer, E.J.K. Zweers, E. van Ballegooie, H.G. ter Brugge, H.W. de Valk, G.H.A. Visser, B.W.J. Mol. (2009) External validation of a clinical scoring system for the risk of gestational diabetes mellitus. Diabetes Research and Clinical Practice 85:1, 96-101
CrossRef220
Sharon J. Herring, Emily Oken, Sheryl L. Rifas-Shiman, Janet W. Rich-Edwards, Alison M. Stuebe, Ken P. Kleinman, Matthew W. Gillman. (2009) Weight gain in pregnancy and risk of maternal hyperglycemia. American Journal of Obstetrics and Gynecology 201:1, 61.e1-61.e7
CrossRef221
Kirsi Laitinen, Tuija Poussa, Erika Isolauri, . (2009) Probiotics and dietary counselling contribute to glucose regulation during and after pregnancy: a randomised controlled trial. British Journal of Nutrition 101:11, 1679
CrossRef222
Theunis Avenant. (2009) Neonatal near miss: a measure of the quality of obstetric care. Best Practice & Research Clinical Obstetrics & Gynaecology 23:3, 369-374
CrossRef223
MF Hebert, X Ma, SB Naraharisetti, KM Krudys, JG Umans, GDV Hankins, SN Caritis, M Miodovnik, DR Mattison, JD Unadkat, EJ Kelly, D Blough, C Cobelli, MS Ahmed, WR Snodgrass, DB Carr, TR Easterling, P Vicini. (2009) Are We Optimizing Gestational Diabetes Treatment With Glyburide? The Pharmacologic Basis for Better Clinical Practice. Clinical Pharmacology & Therapeutics 85:6, 607-614
CrossRef224
Patrice D. Cani. (2009) Gut microbiota and pregnancy, a matter of inner life. British Journal of Nutrition 101:11, 1579
CrossRef225
Yaozhu Chen, William W. Quick, Wenya Yang, Yiduo Zhang, Alan Baldwin, Jane Moran, Victoria Moore, Navita Sahai, Timothy M. Dall. (2009) Cost of Gestational Diabetes Mellitus in the United States in 2007. Population Health Management 12:3, 165-174
CrossRef226
Sung Hoon Yu, Sunmin Park, Hun-Sung Kim, So-Young Park, Chang Hoon Yim, Ki Ok Han, Hyun Koo Yoon, Hak Chul Jang, Ho Yeon Chung, Sung-Hoon Kim. (2009) The prevalence of GAD antibodies in Korean women with gestational diabetes mellitus and their clinical characteristics during and after pregnancy. Diabetes/Metabolism Research and Reviews 25:4, 329-334
CrossRef227
Robert Fraser. (2009) Gestational diabetes mellitus: developments in diagnosis and treatment. Women's Health 5:3, 263-268
CrossRef228
Kristine Y. Lain, Matthew J. Garabedian, Ashi Daftary, Arun Jeyabalan. (2009) Neonatal adiposity following maternal treatment of gestational diabetes with glyburide compared with insulin. American Journal of Obstetrics and Gynecology 200:5, 501.e1-501.e6
CrossRef229
E Albert Reece, Gustavo Leguizamón, Arnon Wiznitzer. (2009) Gestational diabetes: the need for a common ground. The Lancet 373:9677, 1789-1797
CrossRef230
Ma Cristina G Pelaez-Crisologo, Maria Geraldine Assumption Gavina N Castillo-Torralba, Mario R Festin, Ma Cristina G Pelaez-Crisologo. 2009. Different techniques of blood glucose monitoring in women with gestational diabetes for improving maternal and infant health. .
CrossRef231
Yariv Yogev, Boyd E. Metzger, Moshe Hod. (2009) Establishing diagnosis of gestational diabetes mellitus: Impact of the hyperglycemia and adverse pregnancy outcome study. Seminars in Fetal and Neonatal Medicine 14:2, 94-100
CrossRef232
Bengt Persson. (2009) Neonatal glucose metabolism in offspring of mothers with varying degrees of hyperglycemia during pregnancy. Seminars in Fetal and Neonatal Medicine 14:2, 106-110
CrossRef233
A. Michael Weindling. (2009) Offspring of diabetic pregnancy: Short-term outcomes. Seminars in Fetal and Neonatal Medicine 14:2, 111-118
CrossRef234
F. Rossi Pacini. (2009) Le soin diététique en oncologie. Oncologie 11:4, 218-223
CrossRef235
Anatte Karmon, Amalia Levy, Gershon Holcberg, Arnon Wiznitzer, Moshe Mazor, Eyal Sheiner. (2009) Decreased perinatal mortality among women with diet-controlled gestational diabetes mellitus. International Journal of Gynecology & Obstetrics 104:3, 199-202
CrossRef236
Eva Anderberg, Kerstin Berntorp, Elizabeth Crang-Svalenius. (2009) Diabetes and pregnancy: women’s opinions about the care provided during the childbearing year. Scandinavian Journal of Caring Sciences 23:1, 161-170
CrossRef237
Shahzya S Huda, Naveed Sattar, Dilys J Freeman. (2009) Lipoprotein metabolism and vascular complications in pregnancy. Clinical Lipidology 4:1, 91-102
CrossRef238
Daniel A. Enquobahrie, Michelle A. Williams, Chunfang Qiu, Margaret Meller, Tanya K. Sorensen. (2009) Global placental gene expression in gestational diabetes mellitus. American Journal of Obstetrics and Gynecology 200:2, 206.e1-206.e13
CrossRef239
Lionel Carbillon. (2009) Defining a high risk group for perinatal death from fasting plasma glucose level. Early Human Development 85:2, 139
CrossRef240
Frances M Stewart, Jane E Ramsay, Ian A Greer. (2009) Obesity: impact on obstetric practice and outcome. The Obstetrician & Gynaecologist 11:1, 25-31
CrossRef241
Linda A. Barbour. 2009. Diabetes in Pregnancy. , 47-64.
CrossRef242
Tina Saldana, Olga Basso, Donna Baird, Jane Hoppin, Clarice Weinberg, Aaron Blair, Michael Alavanja, Dale Sandler. (2009) Pesticide Exposure and Hypertensive Disorders During Pregnancy. Environmental Health Perspectives
CrossRef243
Stephen F. Thung, Errol R. Norwitz. 2009. Endocrine Diseases of Pregnancy. , 615-658.
CrossRef244
Yvonne W. Cheng, Judith H. Chung, Ingrid Kurbisch-Block, Maribeth Inturrisi, Sherri Shafer, Aaron B. Caughey. (2008) Gestational Weight Gain and Gestational Diabetes Mellitus. Obstetrics & Gynecology 112:5, 1015-1022
CrossRef245
Teresa A. Hillier, Kathryn L. Pedula, Kimberly K. Vesco, Mark M. Schmidt, Judith A. Mullen, Erin S. LeBlanc, David J. Pettitt. (2008) Excess Gestational Weight Gain. Obstetrics & Gynecology 112:5, 1007-1014
CrossRef246
Jane Faith Kapustin. (2008) Postpartum management for gestational diabetes mellitus: Policy and practice implications. Journal of the American Academy of Nurse Practitioners 20:11, 547-554
CrossRef247
Elizabeth A. Buzney, Alexa Boer Kimball. (2008) A critical assessment of composite and coprimary endpoints: A complex problem. Journal of the American Academy of Dermatology 59:5, 890-896
CrossRef248
F.W.F. Hanna, J.R. Peters, J. Harlow, P.W. Jones. (2008) Gestational diabetes screening and glycaemic management; National survey on behalf of the Association of British Clinical Diabetologists. QJM 101:10, 777-784
CrossRef249
Y W Cheng, A B Caughey. (2008) Gestational diabetes: diagnosis and management. Journal of Perinatology 28:10, 657-664
CrossRef250
R. I. G. Holt. (2008) The Hyperglycemia and Adverse Pregnancy Outcomes trial: answers but still more questions about the management of gestational diabetes. Diabetic Medicine 25:9, 1013-1014
CrossRef251
J. D. Walker. (2008) NICE guidance on diabetes in pregnancy: management of diabetes and its complications from preconception to the postnatal period. NICE clinical guideline 63. London, March 2008. Diabetic Medicine 25:9, 1025-1027
CrossRef252
Víctor Hugo González-Quintero, Niki B. Istwan, Debbie J. Rhea, Carmen Maria Tudela, Amy Alicia Flick, Lesley de la Torre, Gary J. Stanziano. (2008) Antenatal Factors Predicting Subsequent Need for Insulin Treatment in Women with Gestational Diabetes. Journal of Women's Health 17:7, 1183-1187
CrossRef253
Harry M. Georgiou, Martha Lappas, George M. Georgiou, Adinda Marita, Valerie J. Bryant, Richard Hiscock, Michael Permezel, Zeinab Khalil, Gregory E. Rice. (2008) Screening for biomarkers predictive of gestational diabetes mellitus. Acta Diabetologica 45:3, 157-165
CrossRef254
S.M. Sadikot. (2008) Should we screen for gestational diabetes mellitus: If so, how?. Diabetes and Metabolic Syndrome: Clinical Research and Reviews 2:3, 159-162
CrossRef255
Patricia J. ENGEL, Roger SMITH, Maxwell W. BRINSMEAD, Stephen J. BOWE, Vicki L. CLIFTON. (2008) Male sex and pre-existing diabetes are independent risk factors for stillbirth. Australian and New Zealand Journal of Obstetrics and Gynaecology 48:4, 375-383
CrossRef256
RINAT GABBAY BEN-ZIV, MOSHE HOD. (2008) GESTATIONAL DIABETES MELLITUS. Fetal and Maternal Medicine Review 19:03,
CrossRef257
Joanna Tieu, Caroline A Crowther, Philippa Middleton, Andrew J McPhee, Joanna Tieu. 2008. Screening for gestational diabetes mellitus for improving maternal and infant health. .
CrossRef258
Jane C. Bell, Jane B. Ford, Carolyn A. Cameron, Christine L. Roberts. (2008) The accuracy of population health data for monitoring trends and outcomes among women with diabetes in pregnancy. Diabetes Research and Clinical Practice 81:1, 105-109
CrossRef259
Melissa M. Bailey, Jonathan G. Boohaker, Peter L. Jernigan, Megan B. Townsend, John Sturdivant, Jane F. Rasco, John B. Vincent, Ronald D. Hood. (2008) Effects of Pre- and Postnatal Exposure to Chromium Picolinate or Picolinic Acid on Neurological Development in CD-1 Mice. Biological Trace Element Research 124:1, 70-82
CrossRef260
RIG Holt, . (2008) Improving pregnancy outcomes for women with diabetes. Practical Diabetes International 25:5, 172-174
CrossRef261
Yaakov Dickstein, Iris Ohel, Amalia Levy, Gershon Holcberg, Eyal Sheiner. (2008) Lack of prenatal care: an independent risk factor for perinatal mortality among macrosomic newborns. Archives of Gynecology and Obstetrics 277:6, 511-514
CrossRef262
Jarosław Ogonowski, Tomasz Miazgowski, Maria B. Czeszyńska, Brygida Jaskot, Magdalena Kuczyńska, Zbigniew Celewicz. (2008) Factors influencing risk of macrosomia in women with gestational diabetes mellitus undergoing intensive diabetic care. Diabetes Research and Clinical Practice 80:3, 405-410
CrossRef263
A. W. Shand, J. C. Bell, A. McElduff, J. Morris, C. L. Roberts. (2008) Outcomes of pregnancies in women with pre-gestational diabetes mellitus and gestational diabetes mellitus; a population-based study in New South Wales, Australia, 19982002. Diabetic Medicine 25:6, 708-715
CrossRef264
Ilknur I. Gumus, Nilgün O. Turhan. (2008) Are patients with positive screening but negative diagnostic test for gestational diabetes under risk for adverse pregnancy outcome?. Journal of Obstetrics and Gynaecology Research 34:3, 359-363
CrossRef265
R. J. Clifton-Bligh, P. McElduff, A. McElduff. (2008) Maternal vitamin D deficiency, ethnicity and gestational diabetes. Diabetic Medicine 25:6, 678-684
CrossRef266
Ecker, Jeffrey L., Greene, Michael F., . (2008) Gestational Diabetes — Setting Limits, Exploring Treatments. New England Journal of Medicine 358:19, 2061-2063
Full Text267
The HAPO Study Cooperative Research Group. (2008) Hyperglycemia and Adverse Pregnancy Outcomes. New England Journal of Medicine 358:19, 1991-2002
Full Text268
Rowan, Janet A., Hague, William M., Gao, Wanzhen, Battin, Malcolm R., Moore, M. Peter, . (2008) Metformin versus Insulin for the Treatment of Gestational Diabetes. New England Journal of Medicine 358:19, 2003-2015
Full Text269
Brian J. DeBosch, Anthony J. Muslin. (2008) Insulin signaling pathways and cardiac growth. Journal of Molecular and Cellular Cardiology 44:5, 855-864
CrossRef270
Xun Zhang, Adriana Decker, Robert W. Platt, Michael S. Kramer. (2008) How big is too big? The perinatal consequences of fetal macrosomia. American Journal of Obstetrics and Gynecology 198:5, 517.e1-517.e6
CrossRef271
Elisabeth R. Mathiesen, Julius Anthony Vaz. (2008) Insulin treatment in diabetic pregnancy. Diabetes/Metabolism Research and Reviews 24:S2, S3-S20
CrossRef272
Diane Farrar, Lelia Duley, Debbie A Lawlor, Diane Farrar. 2008. Alternative strategies for diagnosing gestational diabetes mellitus to improve maternal and infant health. .
CrossRef273
Willibald Zeck, H. David McIntyre. (2008) Gestational Diabetes in Rural East Africa: A Call to Action. Journal of Women's Health 17:3, 403-411
CrossRef274
K. Schellong, E. Rodekamp, T. Harder, J.W. Dudenhausen, A. Plagemann. (2008) Perinatale Prägung und lebenslange Krankheitsrisiken. Der Gynäkologe 41:4, 303-312
CrossRef275
Ramón San Miguel, Ana María López-González, Eduardo Sanchez-Iriso, Javier Mar, Juan M. Cabasés. (2008) Measuring health-related quality of life in drug clinical trials: is it given due importance?. Pharmacy World & Science 30:2, 154-160
CrossRef276
Boyd E. Metzger, Yoo Lee Kim. 2008. Detection and diagnostic strategies for gestational diabetes mellitus. , 156-164.
CrossRef277
Kinneret Tenenbaum-Gavish, Galia Oron, Rony Chen. 2008. Early pregnancy loss and perinatal mortality. , 493-502.
CrossRef278
Oded Langer. 2008. Gestational diabetes: The consequences of not-treating. , 107-117.
CrossRef279
Jeffrey P. Levine. (2008) Type 2 Diabetes Among Women: Clinical Considerations for Pharmacological Management to Achieve Glycemic Control and Reduce Cardiovascular Risk. Journal of Women's Health 17:2, 249-260
CrossRef280
Emily Albertson, Lois Jovanovic. 2008. Medical nutritional therapy for gestational diabetes mellitus. , 196-204.
CrossRef281
Derek J Tuffnell, Serwaa McClean. (2008) Does treatment with 17 α-hydroxyprogesterone caproate increase the risk of gestational diabetes mellitus?. Nature Clinical Practice Endocrinology & Metabolism 4:3, 130-131
CrossRef282
ML Wong, S Butson, W Gatling, MG Masding. (2008) The management of women with gestational diabetes can be stratified according to diagnostic oral glucose tolerance test results. Practical Diabetes International 25:2, 61-63
CrossRef283
Massimo Massi-Benedetti, Marco Orsini Federici, Gian Carlo Di Renzo. 2008. Management of gestational diabetes mellitus. , 188-195.
CrossRef284
Charles J. Glueck, Joel Pranikoff, Dawit Aregawi, Ping Wang. (2008) Prevention of gestational diabetes by metformin plus diet in patients with polycystic ovary syndrome. Fertility and Sterility 89:3, 625-634
CrossRef285
Paul Merlob, Moshe Hod. 2008. Short-term implications: The neonate. , 352-361.
CrossRef286
Angèle Gayet-Ageron, Bénédicte Poncet, Pascale Guerre, Laure Rocher, Elisabeth Dureau-Drevard, Cyrille Colin, Jacques Orgiazzi, Michel Berland, Sandrine Touzet. (2008) Specific information about the WHO guidelines for gestational diabetes screening improves clinical practices. Journal of Evaluation in Clinical Practice 14:1, 36-42
CrossRef287
Kathryn Beardsall, Barbro M.S. Diderholm, David B. Dunger. (2008) Insulin and carbohydrate metabolism. Best Practice & Research Clinical Endocrinology & Metabolism 22:1, 41-55
CrossRef288
David Simmons. (2008) Diagnosis of gestational diabetes mellitus—a comparison of two screening tests. Which is the way ahead?. Nature Clinical Practice Endocrinology & Metabolism 4:2, 72-73
CrossRef289
Dittakarn Boriboonhirunsarn, Prasert Sunsaneevithayakul. (2008) Abnormal results on a second testing and risk of gestational diabetes in women with normal baseline glucose levels. International Journal of Gynecology & Obstetrics 100:2, 147-153
CrossRef290
Y W Cheng, A B Caughey. (2008) Glucose tolerance test: varying diagnostic strategies for gestational diabetes mellitus. Journal of Perinatology 28:1, 1-2
CrossRef291
Sunny Gidda, Aaron Tejani. (2008) “All for one, one for all”: Evaluating composite endpoints in clinical trials. Canadian Pharmacists Journal 141:1, 28-31
CrossRef292
C Phaloprakarn, S Tangjitgamol. (2008) Diagnosis of gestational diabetes mellitus using a modified 100 g oral glucose tolerance test. Journal of Perinatology 28:1, 7-11
CrossRef293
Guido Menato, Simona Bo, Anna Signorile, Marie-Laure Gallo, Ilenia Cotrino, Chiara Botto Poala, Marco Massobrio. (2008) Current management of gestational diabetes mellitus. Expert Review of Obstetrics & Gynecology 3:1, 73-91
CrossRef294
CORNELIA R. GRAVES. (2007) Antepartum Fetal Surveillance and Timing of Delivery in the Pregnancy Complicated by Diabetes Mellitus. Clinical Obstetrics and Gynecology 50:4, 1007-1013
CrossRef295
Nisha Kapoor, Srividhya Sankaran, Steve Hyer, Hassan Shehata. (2007) Diabetes in pregnancy: a review of current evidence. Current Opinion in Obstetrics and Gynecology 19:6, 586-590
CrossRef296
MICHELLE A. RUSSELL, MARSHALL W. CARPENTER, DONALD R. COUSTAN. (2007) Screening and Diagnosis of Gestational Diabetes Mellitus. Clinical Obstetrics and Gynecology 50:4, 949-958
CrossRef297
BOYD E. METZGER. (2007) Long-term Outcomes in Mothers Diagnosed With Gestational Diabetes Mellitus and Their Offspring. Clinical Obstetrics and Gynecology 50:4, 972-979
CrossRef298
A. Vambergue, C. Dognin, A. Boulogne, M. C. Réjou, S. Biausque, P. Fontaine. (2007) Increasing incidence of abnormal glucose tolerance in women with prior abnormal glucose tolerance during pregnancy: DIAGEST 2 study. Diabetic Medicine 0:0, 071119221323004-???
CrossRef299
J. Lepercq. (2007) Conséquences obstétricales et néonatales du diabète gestationnel dans la population du sud de l'île de la Réunion. Gynécologie Obstétrique & Fertilité 35:10, 1080
CrossRef300
M. Virally, M. Laloi-Michelin, T. Meas, N. Ciraru, N. Ouled, V. Médeau, J.P. Kevorkian, J.B. Truc, P.J. Guillausseau. (2007) Occurrence of gestational diabetes mellitus, maternal and fetal outcomes beyond the 28th week of gestation in women at high risk of gestational diabetes. A prospective study. Diabetes & Metabolism 33:4, 290-295
CrossRef301
Amy G. Gottlieb, Henry L. Galan. (2007) Shoulder Dystocia: An Update. Obstetrics and Gynecology Clinics of North America 34:3, 501-531
CrossRef302
M. Kwik, S.K.M. Seeho, C. Smith, A. McElduff, J.M. Morris. (2007) Outcomes of pregnancies affected by impaired glucose tolerance. Diabetes Research and Clinical Practice 77:2, 263-268
CrossRef303
Kirsimarja K. Kestilä, Ulla U. Ekblad, Tapani Rönnemaa. (2007) Continuous glucose monitoring versus self-monitoring of blood glucose in the treatment of gestational diabetes mellitus. Diabetes Research and Clinical Practice 77:2, 174-179
CrossRef304
David J. Pettitt, Lois Jovanovic. (2007) The vicious cycle of diabetes and pregnancy. Current Diabetes Reports 7:4, 295-297
CrossRef305
Jodie M. DODD, Caroline A. CROWTHER, Georgia ANTONIOU, Peter BAGHURST, Jeffrey S. ROBINSON. (2007) Screening for gestational diabetes: The effect of varying blood glucose definitions in the prediction of adverse maternal and infant health outcomes. Australian and New Zealand Journal of Obstetrics and Gynaecology 47:4, 307-312
CrossRef306
J Tieu, CA Crowther, P Middleton, Joanna Tieu. 2007. Dietary advice in pregnancy for preventing gestational diabetes mellitus. .
CrossRef307
Gabie K. B. Ong, Jill K. Hamilton, Mathew Sermer, Philip W. Connelly, Graham Maguire, Bernard Zinman, Anthony J. G. Hanley, Ravi Retnakaran. (2007) Maternal serum adiponectin and infant birthweight: the role of adiponectin isoform distribution. Clinical Endocrinology 67:1, 108-114
CrossRef308
Celene Mulholland, Terry Njoroge, Patricia Mersereau, Jennifer Williams. (2007) Comparison of Guidelines Available in the United States for Diagnosis and Management of Diabetes before, during, and after Pregnancy. Journal of Women's Health 16:6, 790-801
CrossRef309
Jennifer M. DiNallo, Danielle Symons Downs. (2007) The Role of Exercise in Preventing and Treating Gestational Diabetes: A Comprehensive Review and Recommendations for Future Research. Journal of Applied Biobehavioral Research 12:3-4, 141-177
CrossRef310
Peng Chiong TAN, Liza Ping LING, Siti Zawiah OMAR. (2007) Screening for gestational diabetes at antenatal booking in a Malaysian university hospital: The role of risk factors and threshold value for the 50-g glucose challenge test. The Australian and New Zealand Journal of Obstetrics and Gynaecology 47:3, 191-197
CrossRef311
Joseph N. Bottalico. (2007) Recurrent Gestational Diabetes: Risk Factors, Diagnosis, Management, and Implications. Seminars in Perinatology 31:3, 176-184
CrossRef312
Carol J. Homko, William P. Santamore, Valerie Whiteman, Margaret Bower, Phillip Berger, Osnat Geifman-Holtzman, Alfred A. Bove. (2007) Use of an Internet-Based Telemedicine System to Manage Underserved Women with Gestational Diabetes Mellitus. Diabetes Technology & Therapeutics 9:3, 297-306
CrossRef313
David SIMMONS, N. Wah CHEUNG, H. David McINTYRE, Jeff R. FLACK, Janet LAGSTROM, Dianne BOND, Elizabeth JOHNSON, Louise WOLMARANS, Peter WEIN, Ashim K. SINHA, . (2007) The ADIPS pilot National Diabetes in Pregnancy Audit Project. The Australian and New Zealand Journal of Obstetrics and Gynaecology 47:3, 198-206
CrossRef314
Kylie McLACHLAN, Alicia JENKINS, David O?NEAL. (2007) The role of continuous glucose monitoring in clinical decision-making in diabetes in pregnancy. The Australian and New Zealand Journal of Obstetrics and Gynaecology 47:3, 186-190
CrossRef315
Michael J. Fassett, Sonia H.K. Dhillon, Tamara R. Williams. (2007) Effects on perinatal outcome of treating women with 1 elevated glucose tolerance test value. American Journal of Obstetrics and Gynecology 196:6, 597.e1-597.e4
CrossRef316
Andrea L. Campaigne, Deborah L. Conway. (2007) Detection and Prevention of Macrosomia. Obstetrics and Gynecology Clinics of North America 34:2, 309-322
CrossRef317
J. Seth Hawkins, Brian M. Casey. (2007) Labor and Delivery Management for Women With Diabetes. Obstetrics and Gynecology Clinics of North America 34:2, 323-334
CrossRef318
Y W Cheng, A B Caughey. (2007) Gestational diabetes mellitus: what is the optimal treatment modality?. Journal of Perinatology 27:5, 257-258
CrossRef319
S Robinson, A Dornhorst, . (2007) ABCD position statement on screening for gestational diabetes mellitus. Practical Diabetes International 24:4, 192-195
CrossRef320
Bronwyn Anne SINCLAIR, Janet Alison ROWAN, Oliver Timothy HAINSWORTH. (2007) Macrosomic infants are not all equal. The Australian and New Zealand Journal of Obstetrics and Gynaecology 47:2, 101-105
CrossRef321
Nikki Koklanaris, Clarissa Bonnano, David Seubert, Yuzuru Anzai, Richard Jennings, Men-Jean Lee. (2007) Does raising the glucose challenge test threshold impact birthweight in Asian gravidas?. Journal of Perinatal Medicine 35:2, 100-103
CrossRef322
Karen V. Smirnakis, Alicia Plati, Myles Wolf, Ravi Thadhani, Jeffrey L. Ecker. (2007) Predicting gestational diabetes: choosing the optimal early serum marker. American Journal of Obstetrics and Gynecology 196:4, 410.e1-410.e7
CrossRef323
D. Simmons. (2007) Relationship between maternal glycaemia and birth weight in glucose-tolerant women from different ethnic groups in New Zealand. Diabetic Medicine 24:3, 240-244
CrossRef324
Peter Damm, Bettina Breitowicz, Hanne Hegaard. (2007) Exercise, pregnancy, and insulin sensitivity – what is new?. Applied Physiology, Nutrition, and Metabolism 32:3, 537-540
CrossRef325
Arthur H. Friedlander, Gautam Chaudhuri, Lisa Altman. (2007) A past medical history of gestational diabetes: its medical significance and its dental implications. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology 103:2, 157-163
CrossRef326
Martine H. Hollander, K Marieke Paarlberg, Anjoke J. M. Huisjes. (2007) Gestational Diabetes: A Review of the Current Literature and Guidelines. Obstetrical & Gynecological Survey 62:2, 125-136
CrossRef327
Chaturica ATHUKORALA, Caroline A. CROWTHER, Kristyn WILLSON, . (2007) Women with gestational diabetes mellitus in the ACHOIS trial: Risk factors for shoulder dystocia. The Australian and New Zealand Journal of Obstetrics and Gynaecology 47:1, 37-41
CrossRef328
Ank Jonge, Ingrid Sluisveld, Marlies Rijnders, Louis Peeters. (2007) NIV-richtlijn: Zwangerschap bij diabetes. Huisarts en Wetenschap 50:2, 95-99
CrossRef329
Terry T.-K. Huang, Geoff D.C. Ball, Paul W. Franks. (2007) Metabolic syndrome in youth: current issues and challenges. Applied Physiology, Nutrition, and Metabolism 32:1, 13-22
CrossRef330
Patrick M. Catalano. (2007) Management of Obesity in Pregnancy. Obstetrics & Gynecology 109:2, Part 1, 419-433
CrossRef331
A. Ferrara, N. S. Weiss, M. M. Hedderson, C. P. Quesenberry, J. V. Selby, I. J. Ergas, T Peng, G. J. Escobar, D. J. Pettitt, D. A. Sacks. (2007) Pregnancy plasma glucose levels exceeding the American Diabetes Association thresholds, but below the National Diabetes Data Group thresholds for gestational diabetes mellitus, are related to the risk of neonatal macrosomia, hypoglycaemia and hyperbilirubinaemia. Diabetologia 50:2, 298-306
CrossRef332
J.A. Stockman. (2007) Effect of Treatment of Gestational Diabetes Mellitus on Pregnancy Outcomes. Yearbook of Pediatrics 2007, 373-375
CrossRef333
S. Martin. (2006) Risikomanagement bei Typ-2-Diabetes durch Blutzuckerselbstkontrolle. Der Diabetologe 2:6, 493-501
CrossRef334
Michelle A. Russell, Maureen G. Phipps, Courtney L. Olson, H Gilbert Welch, Marshall W. Carpenter. (2006) Rates of Postpartum Glucose Testing After Gestational Diabetes Mellitus. Obstetrics & Gynecology 108:6, 1456-1462
CrossRef335
M Banerjee, JK Cruickshank. (2006) Pregnancy as the prodrome to vascular dysfunction and cardiovascular risk. Nature Clinical Practice Cardiovascular Medicine 3:11, 596-603
CrossRef336
Chaturica Athukorala, Philippa Middleton, Caroline A Crowther, Chaturica Athukorala. 2006. Intrapartum interventions for preventing shoulder dystocia. .
CrossRef337
N. Wah CHEUNG, Jeremy J. N. OATS, H. David McINTYRE. (2006) Author's reply. The Australian and New Zealand Journal of Obstetrics and Gynaecology 46:5, 464-464
CrossRef338
Barry N. J. WALTERS. (2006) Re: Australian carbohydrate intolerance study in pregnant women: Implications for the management of gestational diabetes. The Australian and New Zealand Journal of Obstetrics and Gynaecology 46:5, 463-464
CrossRef339
Xu Xiong, Pierre Buekens, Sotirios Vastardis, Gabriella Pridjian. (2006) Periodontal disease and gestational diabetes mellitus. American Journal of Obstetrics and Gynecology 195:4, 1086-1089
CrossRef340
H Fadl, I Östlund, K Nilsson, U Hanson. (2006) Fasting capillary glucose as a screening test for gestational diabetes mellitus. BJOG: An International Journal of Obstetrics & Gynaecology 113:9, 1067-1071
CrossRef341
Diane Reader, Patricia Splett, Erica P. Gunderson. (2006) Impact of Gestational Diabetes Mellitus Nutrition Practice Guidelines Implemented by Registered Dietitians on Pregnancy Outcomes. Journal of the American Dietetic Association 106:9, 1426-1433
CrossRef342
Larry Rand, Aaron B. Caughey. (2006) Comparison of glyburide and insulin for the management of gestational diabetes in a large managed care organization. American Journal of Obstetrics and Gynecology 195:2, 628-629
CrossRef343
Gavin Jacobson, D. Robin Field, Russell S. Kirby. (2006) Reply. American Journal of Obstetrics and Gynecology 195:2, 629-630
CrossRef344
Jennifer A. Hutcheon, Robert W. Platt, Sara J. Meltzer, Grace M. Egeland. (2006) Is birth weight modified during pregnancy? Using sibling differences to understand the impact of blood glucose, obesity, and maternal weight gain in gestational diabetes. American Journal of Obstetrics and Gynecology 195:2, 488-494
CrossRef345
H. Kleinwechter, U. Schäfer-Graf. (2006) Diabetes und Schwangerschaft. Der Diabetologe 2:4, 351-366
CrossRef346
J H Chung, K J Voss, A B Caughey, D A Wing, E J D Henderson, C A Major. (2006) Role of patient education level in predicting macrosomia among women with gestational diabetes mellitus. Journal of Perinatology 26:6, 328-332
CrossRef347
Bronwen F. Kahn, Jill K. Davies, Anne M. Lynch, Regina M. Reynolds, Linda A. Barbour. (2006) Predictors of Glyburide Failure in the Treatment of Gestational Diabetes. Obstetrics & Gynecology 107:6, 1303-1309
CrossRef348
Melissa Scollan-Koliopoulos, Sharon Guadagno, Elizabeth A. Walker. (2006) Gestational Diabetes Management. The Nurse Practitioner 31:6, 14???23
CrossRef349
(2006) Discussion. American Journal of Obstetrics and Gynecology 194:6, 1582-1583
CrossRef350
Laurel S. Thorlacius, George Blakney, John Krahn, Fiona Bamforth, Trefor N. Higgins. (2006) Biochemistry testing associated with pregnancy and the newborn period—A lot has changed since you were a baby!. Clinical Biochemistry 39:5, 519-541
CrossRef351
G. Blake McLaughlin, Yvonne W. Cheng, Aaron B. Caughey. (2006) Women with one elevated 3-hour glucose tolerance test value: Are they at risk for adverse perinatal outcomes?. American Journal of Obstetrics and Gynecology 194:5, e16-e19
CrossRef352
Marco Orsini Federici, Andrea Mosca, Roberto Testa, Annunziata Lapolla, Paolo Andreani, Massimo Massi Benedetti. (2006) National survey on the execution of the oral glucose tolerance test (OGTT) in a representative cohort of Italian laboratories. Clinical Chemistry and Laboratory Medicine 44:5, 568-573
CrossRef353
D Tuffnell, J West, S Walkinshaw. (2006) Correspondence: Author's Reply. BJOG: An International Journal of Obstetrics & Gynaecology 113:5, 616-616
CrossRef354
N.W. Cheung, D. Chipps, S. Hendon, M. McLean. (2006) Letter regarding “Comparison of blood glucose meters in Australia” [Diab. Res. Clin. Pract., doi:10.1016/j.diabres.2005.05.13]. Diabetes Research and Clinical Practice 72:2, 216-217
CrossRef355
Sarah Friedman, Fady Khoury-Collado, Mudar Dalloul, David M. Sherer, Ovadia Abulafia. (2006) Glucose challenge test threshold values in screening for gestational diabetes among black women. American Journal of Obstetrics and Gynecology 194:5, e46-e48
CrossRef356
EA Masson, SW Lindow. (2006) Correspondence: Where is the evidence to screen for gestational diabetes?. BJOG: An International Journal of Obstetrics & Gynaecology 113:5, 615-616
CrossRef357
J. C. Malcolm, M. L. Lawson, I. Gaboury, G. Lough, E. Keely. (2006) Glucose tolerance of offspring of mother with gestational diabetes mellitus in a low-risk population. Diabetic Medicine 23:5, 565-570
CrossRef358
W. A. Cutchie, N. W. Cheung, D. Simmons. (2006) Comparison of international and New Zealand guidelines for the care of pregnant women with diabetes. Diabetic Medicine 23:5, 460-468
CrossRef359
Jodie M. Dodd, Caroline A. Crowther. (2006) Cochrane reviews in pregnancy: The role of perinatal randomized trials and systematic reviews in establishing evidence. Seminars in Fetal and Neonatal Medicine 11:2, 97-103
CrossRef360
E Cosson, M Benchimol, L Carbillon, I Pharisien, J Pariès, P Valensi, B Lormeau, S Bolie, M Uzan, JR Attali. (2006) Universal rather than selective screening for gestational diabetes mellitus may improve fetal outcomes. Diabetes & Metabolism 32:2, 140-146
CrossRef361
R. Fraser. (2006) Gestational diabetes: after the ACHOIS trial. Diabetic Medicine 23:s1, 8-11
CrossRef362
G. Hawthorne. (2006) Metformin use and diabetic pregnancy-has its time come?. Diabetic Medicine 23:3, 223-227
CrossRef363
Ellen W Seely. (2006) Does treatment of gestational diabetes mellitus affect pregnancy outcome?. Nature Clinical Practice Endocrinology & Metabolism 2:2, 72-73
CrossRef364
Derek Tuffnell, Jane West, Steve Walkinshaw. (2006) Commentary: Time to screen for, and treat, gestational diabetes. BJOG: An International Journal of Obstetrics & Gynaecology 113:1, 3-4
CrossRef365
(2006) Current awareness in prenatal diagnosis. Prenatal Diagnosis 26:1, 94-99
CrossRef366
F Abourawi. (2006) Diabetes Mellitus and Pregnancy. Libyan Journal of Medicine 1:1, 28-41
CrossRef367
J LEAHY. (2006) Effect of Treatment of Gestational Diabetes Mellitus on Pregnancy OutcomesCrowther CA, for the Australian Carbohydrate Intolerance Study in Pregnant Women (ACHOIS) Trial Group (Univ of Adelaide, Australia; et al) N Engl J Med 352:2477–2486, 2005§. Yearbook of Endocrinology 2006, 46-48
CrossRef368
N. Wah CHEUNG, Jeremy J. N. OATS, H. David MCINTYRE. (2005) Australian carbohydrate intolerance study in pregnant women: implications for the management of gestational diabetes. The Australian and New Zealand Journal of Obstetrics and Gynaecology 45:6, 484-485
CrossRef369
Mark I. Evans, Robert S. Galen, David W. Britt. (2005) Principles of Screening. Seminars in Perinatology 29:6, 364-366
CrossRef370
R. Bellomo, M. Egi. (2005) Glycemic Control in the Intensive Care Unit: Why We Should Wait for NICE-SUGAR. Mayo Clinic Proceedings 80:12, 1546-1548
CrossRef371
O. Langer. (2005) Ultrasound biometry evolves in the management of diabetes in pregnancy. Ultrasound in Obstetrics and Gynecology 26:6, 585-595
CrossRef372
Gillman, Matthew W., . (2005) Developmental Origins of Health and Disease. New England Journal of Medicine 353:17, 1848-1850
Full Text373
(2005) Treatment of Gestational Diabetes Mellitus. New England Journal of Medicine 353:15, 1629-1630
Full Text374
IOANNIS ILIAS, CHARALAMBOS PAPAGEORGIOU, KYRIAKOS KATSADOROS, EVANGELIA ZAPANTI, ELENI ANASTASIOU. (2005) PRELIMINARY REPORT: PSYCHOLOGICAL ASSESSMENT OF GREEK WOMEN WITH DIABETES DURING PREGNANCY 1. Perceptual and Motor Skills 101:2, 628-630
CrossRef375
C. Mathieu. (2005) Diabetes and pregnancy: beyond glucose?. Diabetologia 48:9, 1714-1715
CrossRef376
Claire S Duvernoy. (2005) Coronary heart disease in women: what do we know now?. Future Cardiology 1:5, 617-628
CrossRef377
Greene, Michael F., Solomon, Caren G., . (2005) Gestational Diabetes Mellitus — Time to Treat. New England Journal of Medicine 352:24, 2544-2546
Full Text378
IOANNIS ILIAS. (2005) PRELIMINARY REPORT: PSYCHOLOGICAL ASSESSMENT OF GREEK WOMEN WITH DIABETES DURING PREGNANCY. Perceptual and Motor Skills 101:6, 628
CrossRef
- Letters
